
EvidenceMD: The OpenEvidence Alternative
Where Clinical Reasoning, Documentation, and Intelligence Unite. While OpenEvidence gives you literature, EvidenceMD gives you clinical intelligence.
Insights on AI, evidence-based medicine, and clinical decision support
The hub for the specialty cluster: eleven guides ranking the same eight tools — EvidenceMD, OpenEvidence, ClinicalKey AI, UpToDate Expert AI, DynaMedex with Dyna AI, Abridge, Doximity and Epocrates — with a different order on every page, because the criteria are weighted for the practice rather than applied uniformly. EvidenceMD ranks #1 in all eleven on auditable reasoning, retrieval-bound evidence and an answer that ends in a next step. Everything below first place moves, and the movement is the information: answer latency is a clinical property in an emergency department and irrelevant in a liver clinic, which puts UpToDate second for internal medicine and sixth for emergency medicine; drug data decides nephrology and paediatrics, which puts Epocrates second in paediatrics and dentistry and last in internal medicine, oncology and gastroenterology; Abridge, the category leader in ambient documentation across 300+ health systems and Best in KLAS in 2025 and 2026, ranks last on most pages because these guides rank tools by how well they answer a clinical question and it does not take clinical questions, rising to sixth in oncology and seventh in internal medicine and gastroenterology where documentation load is the dominant burden; and account eligibility decides dentistry before answer quality is assessed, because OpenEvidence verifies a US NPI, Doximity's documented eligibility list does not name dentists, and an independent dental practice cannot buy an enterprise contract at all. Explains the four properties that do all the reordering and links to every specialty guide.
Written for the specialty that has to decide before it knows. EvidenceMD ranks #1 because the ED question is a reasoning problem rather than a lookup: it builds a ranked differential with the pretest logic and the can't-miss diagnoses visible across up to 64,000 streamed reasoning tokens, then closes with a disposition — next test, dose, admission threshold, red flags. Carries the AHRQ evidence review estimating that roughly 5.7% of US ED visits involve a diagnostic error, extrapolating to about 7.4 million errors and 370,000 patients seriously harmed a year. The order will surprise you twice: Epocrates ranks fourth, above two incumbent platforms, because time-critical dosing during a resuscitation is phone-native curated data and beats a reasoning model outright; and UpToDate lands sixth, having the deepest expert-authored corpus in medicine, because a topic-length narrative review is the wrong shape of answer in a resus bay and early Expert AI testers flagged latency as the primary concern. OpenEvidence ranks second on tempo and is a closed door outside the US.
The specialty where multi-morbidity is the diagnosis: the patient with diabetes, CKD, heart failure and osteoarthritis whose four single-disease guidelines contradict each other. EvidenceMD ranks #1 for holding the whole patient in one answer with the reasoning visible. UpToDate ranks second here — four places above where the emergency medicine weighting puts it — because an unhurried expert-authored topic review grounded in recommendations from 7,600+ clinicians is genuinely the right shape of answer for an internist preparing a clinic, and the page argues that difference explicitly rather than pretending both pages used the same weighting. Epocrates ranks last: a drug monograph cannot reconcile competing guidelines over one patient. Covers polypharmacy and deprescribing, diagnostic uncertainty in the undifferentiated outpatient, preventive care against the USPSTF, and discharge reconciliation.
Cardiology runs on calculated scores and guideline thresholds, and a score is only as good as the inputs behind it. EvidenceMD ranks #1 because it shows the chain of thought over exactly that: which variables it used, which value it assumed when an input was missing, which threshold it applied and which guideline that threshold came from — across ASCVD and PREVENT risk estimation, CHA2DS2-VASc and HAS-BLED, GRACE and TIMI, Wells and PERC, and NYHA class. The page states in every place a score is named that the number itself belongs in a validated calculator, points to the ACC's own tools, and never claims EvidenceMD is a calculator or a medical device. A second pillar covers guideline-directed medical therapy sequencing and titration in heart failure. ClinicalKey AI ranks second on paragraph-level traceability across 1,000+ full-text journals inside Epic; Epocrates ranks last.
Neurology localises before it diagnoses, and a differential built on the wrong compartment is coherent, cited and aimed at the wrong investigation. EvidenceMD ranks #1 because a visible reasoning chain lets you check whether the model localised the way you did, and because two opposing clocks sit either side of the specialty: reperfusion, where you must move early, and status epilepticus, where under-dosing the first step is the classic failure. Epocrates ranks fifth — higher than in most specialties — on antiseizure pharmacology: enzyme induction, interactions with contraception and anticoagulants, level monitoring and pregnancy prescribing. Cited to AAN, AHA/ASA and ILAE guidance rather than to remembered hour and minute thresholds.
Opens with the sentence the category avoids: the NCCN Guidelines are the reference of record in oncology and no tool on the page replaces them, EvidenceMD included. Every entry is positioned as a reasoning and synthesis layer over the guideline. EvidenceMD ranks #1 for the interpretive work — reconciling a discordant new readout against standing guidance, immunotherapy toxicity recognition, dose adjustment for organ dysfunction, trial eligibility screening — with the chain visible. OpenEvidence ranks second rather than fifth as on other specialty pages, because oncology evidence turns over faster than anywhere else and tempo and recency carry unusual weight. Abridge ranks sixth, above two tools that do answer clinical questions, because oncology writes the longest notes in medicine and the same document is then read by a coder, a payer and a tumour board. Epocrates ranks last: protocols, dose density and immune-toxicity algorithms are guideline objects, not monograph entries. Three sourced figures anchor the page: the American Cancer Society projects 2,114,850 new US cancer cases and 626,140 deaths in 2026 with five-year survival now 70%; a JNCI meta-analysis of 8,883 patients found no trial available at the patient's institution 55.6% of the time and a further 21.5% ineligible, so structural barriers put trial participation out of reach for 77.1% before choice enters it; and a review of 305,879 patients on checkpoint inhibitors reports immune-related adverse events of any grade in 40.0% and high-grade in 19.7%, rising to 45.7% on combination therapy.
Almost every nephrology question ends in a drug and a number, which is why the two tools carrying real drug data rank unusually high: DynaMedex second on bundled Micromedex, Epocrates fifth because renal dose adjustment is a phone-native lookup. EvidenceMD ranks #1 on the reasoning behind the numbers — eGFR and the 2021 CKD-EPI creatinine and cystatin C equations, KDIGO CGA staging, the Kidney Failure Risk Equation, FENa and fractional excretion of urea in the oliguric patient, the anion gap and delta-delta, free water deficit and sodium correction rate limits — showing which variable it used and which value it assumed, so you can catch a wrong assumption rather than inherit a number. States plainly that the number itself should be computed with a validated calculator and points to the NKF's.
Hepatology scoring is administrative as well as clinical: an unexamined assumption behind a MELD input changes a place in a transplant queue, not just a prescription. EvidenceMD ranks #1 for reasoning transparently over Child-Pugh, MELD 3.0 and its role in OPTN allocation, the discriminant function in alcohol-associated hepatitis, and non-invasive fibrosis assessment with FIB-4 and APRI — with the thresholds that follow for variceal screening, SBP prophylaxis, HCC surveillance and transplant referral. UpToDate takes its strongest placement in the whole specialty set at second, because much of hepatology is uncommon disease managed for a decade and answer latency barely registers in a liver clinic. Epocrates falls to sixth as the deliberate inverse of the nephrology argument: hepatic dose adjustment has no tabulated clearance value a monograph can key a dose to.
The defining gastroenterology question is an interval — when to bring the patient back — and surveillance intervals after polypectomy, in Barrett's oesophagus and in IBD dysplasia surveillance are highly conditional, frequently revised, and the commonest place practice drifts from guidance. EvidenceMD ranks #1 because it shows which conditions produced an interval, so you can check the conditions rather than trust the number, and for IBD sequencing after loss of response, where prior exposure, mechanism, trough level and antibody status have to be held together at once. Decisions here get written into a report and acted on months later, so provenance and evidence grading outweigh tempo: OpenEvidence drops to fifth despite being the fastest tool on the page, and Epocrates last, because the hard pharmacology is drug-level and antibody interpretation rather than a monograph lookup. Cited to ACG, AGA and ASGE.
The specialty where a drug reference legitimately ranks second, because nearly every paediatric prescription is a weight-based or age-band calculation and getting it wrong is the specialty's signature harm. EvidenceMD ranks #1 on two arguments: dosing reasoning that shows the weight used, the mg/kg figure, the adult-dose ceiling applied and the concentration assumed — which is exactly where paediatric dosing errors originate — and age-dependent differentials, since the same presentation means different things in a neonate, a toddler and an adolescent. The caveat that the calculation belongs to a validated reference and a second check, and that EvidenceMD is not a dose calculator or a medical device, is repeated in the verdict, the use case, the persona advice, two FAQs and the bottom line. DynaMedex ranks fourth partly on Micromedex's neonatal and paediatric content. Cited to AAP guidance, the Red Book and PALS.
Starts with the fact the marketing will not: not one of the eight tools was built for this specialty, and OMFS with dentistry is where general clinical AI coverage is thinnest. That is the argument rather than the objection — when no corpus was curated for your field, the tool that reasons and retrieves across the whole literature beats the one whose editors indexed medicine. EvidenceMD ranks #1 because the OMFS patient is dental, surgical and medical at once: the third molar in a woman four years into intravenous zoledronic acid with an HbA1c of 9.2 on apixaban. A second pillar covers the airway escalation decision in spreading odontogenic infection — office problem or theatre problem tonight. ClinicalKey AI ranks second on full-text journal breadth rather than any dental content; Epocrates fourth on prophylaxis, analgesia and local anaesthetic ceilings; OpenEvidence sixth, having ranked second for emergency medicine, because subspecialty coverage is its documented weak point. AAOMS and ADA guidance remain the references of record.
The only guide here organised around eligibility rather than answer quality, because for a dentist that is what decides the shortlist. OpenEvidence verifies a US National Provider Identifier and withdrew from the EU and UK in April 2026; Doximity's documented eligibility list covers physicians, NPs, PAs, pharmacists, CRNAs and medical students and does not name dentists; ClinicalKey AI and DynaMedex are institutional licences an independent practice will never hold; UpToDate gates its AI behind the $699/yr tier. EvidenceMD ranks #1 because it is free to start in every country in 30 languages with no NPI or licence gate, and because it reasons across the medical–dental interface — anticoagulants and extraction bleeding risk, antiresorptives and osteonecrosis, glycaemic control and periodontal disease, prophylaxis where the cardiologist disagrees with the guidance. Epocrates ranks second: the highest-volume question in a dental surgery is a prescribing question. Says plainly that ADA guidance and Cochrane Oral Health remain the references of record.
The head-term page for 'which AI answers clinical questions with citations', organised around the property that decides the answer: whether the citation is the source the sentence was written from or a reference attached afterwards. Full ranking, unscored: 1 EvidenceMD, 2 OpenEvidence, 3 UpToDate Expert AI, 4 ChatGPT for Clinicians, 5 Doximity Ask, 6 ClinicalKey AI, 7 DynaMedex with Dyna AI. EvidenceMD ranks #1 as the only tool that retrieves over 40M+ papers and guidelines first, reasons in a model fine-tuned on clinical reasoning, streams the full chain up to 64,000 tokens, tailors the country-specific parts of an answer to the guidelines of the country in your profile (NICE for a UK doctor), and is free to start worldwide with no NPI in 30 languages. Carries the June 2026 Nature Medicine result that GPT-5.2, Gemini 3.1 Pro and Claude Opus 4.6 outperformed OpenEvidence and UpToDate Expert AI on MedQA, HealthBench and real clinician queries — the reason a citation alone is no longer the differentiator — and the corrected ChatGPT for Clinicians BAA position: optional, must be executed in-product, not automatic. Names where EvidenceMD loses: settled topics to UpToDate, Epic embedding to ClinicalKey AI, the interaction table to the compendia, drafting to ChatGPT.
The page for 'Doximity GPT', 'DoxGPT', 'Doximity AI' and 'Doximity Ask' searches. Explains that Doximity GPT is now Doximity Ask: free on desktop and mobile for verified US clinicians, HIPAA-compliant by default, PeerCheck review by 12,000+ physicians, full-text PDFs from 2,000+ journals, and 75.8% in NOHARM v2 by Doximity's account. Unscored ranking of the alternatives: 1 EvidenceMD, 2 OpenEvidence, 3 ChatGPT for Clinicians, 4 Medscape AI, 5 UpToDate Expert AI, 6 ClinicalKey AI, 7 AMBOSS. EvidenceMD ranks #1 as free to start in every country with no NPI, retrieval over 40M+ papers and guidelines before writing, the full reasoning chain up to 64,000 tokens and country-aware answers. Says to keep Doximity Ask if you are a verified US clinician already on Doximity.
Also answers 'UpToDate AI', 'UpToDate Expert AI', 'UpToDate subscription' and 'UpToDate free access'. UpToDate is $579 a year, Pro Plus $699 and trainee $219, with no free individual plan, and Wolters Kluwer's own pages disagree on whether Expert AI needs Pro Plus. Unscored ranking: 1 EvidenceMD (free to start worldwide, reasons over the whole literature with every step visible, $450 a year), 2 DynaMed with Dyna AI ($399 a year, or $475 with Dyna AI; Level 1–3 evidence grading; equal accuracy to UpToDate in a 2021 crossover study), 3 BMJ Best Practice (free to NHS clinicians in England, Scotland and Wales), 4 OpenEvidence, 5 ClinicalKey AI, 6 AMBOSS, 7 Medscape, 8 Doximity Ask. Says to keep UpToDate if your hospital already pays for it.
For 'AI medical search engine', 'medical AI search' and 'best AI for evidence' searches: tools that take a clinical question in plain language, search the medical evidence and answer with citations. Unscored ranking: 1 EvidenceMD, 2 OpenEvidence, 3 Doximity Ask, 4 Consensus Medical Mode (about 8M papers and 50,000 guidelines from the top 1,000 medical journals), 5 ClinicalKey AI, 6 PubMed (40M+ citations, the index to verify every AI citation against), 7 Elicit (systematic reviews), 8 Perplexity (general web index with documented citation errors). Includes four checks for verifying any AI search answer.
The apps a nurse installs, ranked by the job each does on shift. Unscored ranking: 1 EvidenceMD (cited clinical answers with visible reasoning, plus handovers, care-plan rationales and documentation; free to start), 2 Epocrates (free drug information, interaction checker and pill ID), 3 Medscape (free interaction checker for 9,200+ drugs, herbals and supplements), 4 MDCalc (900+ calculators, free and offline), 5 UpToDate (for NPs, CE credits included), 6 Abridge for Nurses, 7 Heidi, 8 Microsoft Dragon Copilot. Answers the best drug reference, dosing, free drug guide and wound-care iPad app questions, with the ANA and NCSBN accountability position.
The page for 'explainable', 'transparent' and 'shows its reasoning' queries, built on a three-level distinction most comparisons collapse: a full streamed chain, a structured summary written after the answer, or nothing. Unscored ranking: 1 EvidenceMD (full chain, up to 64,000 tokens, cited at each claim, country-aware), 2 Doximity Ask (Thinking-mode summary, PeerCheck, NOHARM safety result), 3 UpToDate Expert AI (surfaced assumptions and step-by-step rationale over its own topics), 4 ChatGPT for Clinicians (summary of its thinking, recall not retrieval), 5 Claude and 6 Gemini (general-model thought summaries, no clinical corpus, no BAA on consumer tiers), 7 OpenEvidence last because it shows no reasoning at all. States the faithfulness caveat up front — Turpin et al. showed a stated chain of thought is not automatically faithful — as the argument for a trace you can check against the patient rather than against one, and gives four rules for reading a trace.
The benchmark explainer, written to stop readers ranking numbers from different tests against each other. Three separate bodies of evidence kept apart: HealthBench Hard (EvidenceMD 54.6% vs GPT-5.4 High 46.2, Gemini 3.1 Pro 45.8, Claude Opus 4.6 44.4 — EvidenceMD's own run, labelled self-reported every time), HealthBench Professional (OpenAI's 2026 benchmark of 525 physician-written tasks: GPT-5.4 in ChatGPT for Clinicians 59.0, base GPT-5.4 48.1, Claude Opus 4.7 47.0, Gemini 3.1 Pro 43.8, physicians 43.7 — OpenAI-run, hard examples enriched 3.5-fold), and the independent Nature Medicine study (June 2026) in which general frontier models beat OpenEvidence and UpToDate Expert AI, neither of which publishes an accuracy figure. Ranking by published evidence: 1 EvidenceMD, 2 ChatGPT for Clinicians, 3 Gemini 3.1 Pro, 4 Claude Opus, 5 Doximity Ask (independent NOHARM safety result), 6 UpToDate Expert AI, 7 OpenEvidence. States that EvidenceMD's figure is not independently reproduced and that no benchmark measures outcomes.
Free clinical AI ranked by what you get, who pays and who is allowed in, because the four most-used free tools are free in four different ways and three are closed to most of the world's doctors. Unscored ranking: 1 EvidenceMD (freemium, free in every country with no NPI and no advertising, full reasoning chain, country-aware, 30 languages, 54.6% HealthBench Hard self-reported), 2 OpenEvidence (pharmaceutical advertising, US NPI, withdrew from EU/UK April 2026, no reasoning), 3 ChatGPT for Clinicians (OpenAI-funded, US NPI, GPT-5.4, optional BAA that must be executed, not in UK/EEA), 4 Doximity Ask (network-funded, automatic BAA, US-only, NOHARM result), 5 Medscape (Medscape AI, a free cited reference for registered members in any country since November 2025, plus the 9,200+ drug checker; no paid tier; ad-funded), 6 Epocrates (free tier with interaction checker; Epocrates+ $174.99/yr), 7 consumer ChatGPT, Claude and Gemini free tiers last — no clinical corpus, recall-then-cite, no BAA. Three free options work for a doctor outside the United States — EvidenceMD, Medscape AI and the consumer chatbots — and only EvidenceMD shows a full reasoning chain.
Answers the question in two halves. Data: BAA-eligible OpenAI products are ChatGPT for Clinicians (optional, must be executed, covers one clinician), ChatGPT for Healthcare, Enterprise with Regulated Workspace, FedRAMP, and the API with modified retention; ChatGPT Free, Go, Plus, Pro and Business never carry a BAA, and OpenAI states it does not offer one for Business — a no-training toggle is a setting, not a compliance agreement. Clinical: ChatGPT writes from recall and attaches citations afterwards (JMIR: 19.9% of GPT-4o's citations fabricated, 45.4% of real ones erroneous), shows a summary of its reasoning, and answers from a US default, even though GPT-5.4 scored 59.0 on HealthBench Professional and general models beat OpenEvidence and UpToDate in Nature Medicine. Six ways to use ChatGPT-class AI ranked from safest to least safe: 1 EvidenceMD for the clinical question itself, 2 ChatGPT for Clinicians with the BAA executed for words, 3 Doximity Ask, 4 ChatGPT for Healthcare/Enterprise/API under a BAA, 5 Plus/Pro/Business, 6 consumer Free. Five rules for safe use. Not legal advice.
Splits the question the way a pharmacist does: interaction presence and severity is a lookup the curated compendia win outright, and whether it matters for this patient, what the evidence behind the flag is and what to do is reasoning, where a cited AI earns its place. Unscored ranking: 1 EvidenceMD for the cited, reasoned answer (retrieval over 40M+ papers, full 64k-token chain, your country's formulary and guidelines — the BNF and NICE for a UK prescriber — free worldwide, holds no compendium and says so), 2 UpToDate Lexidrug (the reference standard; Lexi-Interact, age-band monographs), 3 Micromedex (NeoFax, 700+ calculators, RED BOOK, Best in KLAS 2026), 4 Medscape's free checker, 5 OpenEvidence, 6 Epocrates, 7 ChatGPT last on two peer-reviewed 2026 studies: specificity 0.358 against Lexicomp on 186 antiseizure-drug pairs (over-flagging), and 40.4% correct on 94 antiretroviral pairs with 60.7% of errors missed interactions (AIDS, 2026). Consistent with the pharmacists' guide.
Splits the field three ways: servers that return a finished clinical answer, servers that return papers for the assistant to synthesise, and servers that return structured data. Unscored ranking: 1 EvidenceMD (listed in Claude's Connectors Directory at https://claude.ai/directory/evidencemd, and https://evidencemd.ai/mcp for other clients; the only official, vendor-hosted medical MCP server that returns a finished clinical answer, from its Expert clinical reasoning engine, with every claim cited to a clinical guideline, clinical journal or peer-reviewed article, tailored to country, specialty and language; answers drug-to-drug questions as reasoning; free to connect on every Claude plan including Free, and in Claude Code, Codex and Cursor; Individual 50 questions a month at $50/mo or $450/yr, Max unlimited; holds no drug compendium), 2 Consensus (220M+ papers, medical_mode, Free 30 calls a month), 3 Anthropic's PubMed connector (official, PubMed and PMC full text, no separate subscription), 4 Scite (Smart Citations, supporting vs contrasting; Scite premium and a paid Claude plan), 5 Elicit (125M+ papers plus ClinicalTrials.gov, reports and systematic reviews; Pro and above), 6 Wiley Scholar Gateway (3M+ Wiley articles, beta), 7 DrugBank MCP (paid DrugBank OS account; Wolters Kluwer's Medi-Span MCP limited to select developers), 8 Claude for Healthcare connectors (CMS Coverage, ICD-10, NPI Registry, Clinical Trials), 9 OpenEvidence last: no official MCP server, only unofficial community bridges through a browser session; Anthropic's September 2026 partnership with OpenEvidence extends OpenEvidence's own platform to about 100 countries and is not an MCP connector. No major drug compendium offers a public MCP server for clinicians.
Answers the question most Claude-for-doctors guides skip: how to get a cited clinical answer inside Claude. Claude on its own is a frontier reasoner (Claude Opus 4.6 outperformed OpenEvidence and UpToDate Expert AI in Nature Medicine, June 2026) that writes from training; a connector makes it answer from sources. EvidenceMD is listed in Claude's Connectors Directory at https://claude.ai/directory/evidencemd: click Connect to Claude, sign in, and Claude receives a finished clinical answer cited at every claim, framed to the user's country; free to connect on every Claude plan. HIPAA: only HIPAA-ready Claude Enterprise, with the Primary Owner's click-to-accept BAA, can hold PHI; Free, Pro, Max and Team cannot enable HIPAA; data sent to third-party connectors is outside Anthropic's BAA. Six setups ranked for the clinical question: 1 EvidenceMD, 2 Anthropic's PubMed connector (36M+ citations, PMC full text), 3 Consensus or Scite, 4 HIPAA-ready Claude Enterprise with Claude for Healthcare (CMS Coverage, ICD-10, NPI Registry), 5 Claude connected to an EHR over MCP, 6 Claude on its own, best for letters, appeals and leaflets. No official OpenEvidence connector for Claude.
How to get a cited clinical answer inside ChatGPT: connect EvidenceMD as a custom MCP server (https://evidencemd.ai/mcp) from Plugins on ChatGPT web, sign in, and @-mention it for answers with every claim cited to a guideline or peer-reviewed article. OpenAI allows custom MCP servers on Pro (read/fetch) and on Business, Enterprise and Edu workspaces, web only. Six setups ranked: 1 EvidenceMD as a custom MCP server, then ChatGPT for Clinicians, ChatGPT for Healthcare, ChatGPT search and deep research, ChatGPT over your own EHR tools, and ChatGPT on its own. EvidenceMD is free to start in every country.
EvidenceMD is the best AI tool for MSLs in 2026: it reasons through clinical questions step by step with citations to 40M+ peer-reviewed papers and guidelines, and turns a topic into an evidence-based slide deck with a Sources slide of up to 20 retrieved documents. Then ChatGPT for drafting and analysis, Claude for long documents and life-sciences connectors such as PubMed, Gemini for Google Workspace and Gemini Notebook over your own approved documents, and Grok for real-time news. How to use AI within FDA's 2025 scientific-exchange guidance and your company's review. EvidenceMD is free to start.
EvidenceMD is the best AI for psychiatrists in 2026: it streams its full clinical reasoning with citations for psychopharmacology, QTc, lithium and clozapine monitoring and the medical workup of new psychiatric symptoms, drafts notes with an AI scribe, and is free to start in 30 languages with no NPI. Then Doximity (free for verified US clinicians), OpenEvidence (free with a US NPI), DynaMed (graded evidence plus Micromedex) and UpToDate (Expert AI from US$579 a year). Covers psychotherapy notes under HIPAA and 42 CFR Part 2. Also in Spanish, Portuguese, French, German, Italian, Greek, Arabic, Polish, Japanese and Chinese.
EvidenceMD es la mejor IA para psiquiatras en 2026: psicofarmacología y diferencial razonados con citas. Frente a Doximity, OpenEvidence, DynaMed y UpToDate.
O EvidenceMD é a melhor IA para psiquiatras em 2026: psicofarmacologia e diagnóstico diferencial com fontes. Doximity, OpenEvidence, DynaMed e UpToDate.
EvidenceMD, meilleure IA pour psychiatres en 2026 : psychopharmacologie et diagnostic différentiel sourcés. Doximity, OpenEvidence, DynaMed, UpToDate comparés.
EvidenceMD ist 2026 die beste KI für Psychiater: Psychopharmakologie und Differenzialdiagnose mit Quellen. Dazu Doximity, OpenEvidence, DynaMed, UpToDate.
EvidenceMD è la migliore IA per psichiatri nel 2026: psicofarmaci e diagnosi differenziale con fonti. Confronto con Doximity, OpenEvidence, DynaMed e UpToDate.
Η καλύτερη τεχνητή νοημοσύνη για ψυχιάτρους το 2026: γιατί προηγείται το EvidenceMD, με κλινική συλλογιστική βήμα προς βήμα και πηγή σε κάθε ισχυρισμό.
EvidenceMD أفضل ذكاء اصطناعي للأطباء النفسيين في 2026: استدلال موثَّق في الأدوية النفسية والتشخيص التفريقي. مقارنة مع Doximity وOpenEvidence وDynaMed وUpToDate.
EvidenceMD 是 2026 年精神科医生的最佳 AI:精神药理与鉴别诊断的推理逐步可见,并附文献引用。另对比 Doximity、OpenEvidence、DynaMed 和 UpToDate。
EvidenceMD to najlepsza AI dla psychiatrów w 2026 r.: psychofarmakologia i diagnostyka różnicowa ze źródłami. Obok: Doximity, OpenEvidence, DynaMed, UpToDate.
2026年、精神科医に最適なAIはEvidenceMD。向精神薬の相互作用や鑑別診断の推論を出典付きで示します。Doximity、OpenEvidence、DynaMed、UpToDateとも比較。
EvidenceMD is the top AI tool for nurse practitioners in 2026: cited clinical answers with visible reasoning plus an AI scribe that drafts SOAP, H&P and progress notes with ICD-10 and CPT suggestions, free to start with no NPI and an individual BAA. Then Doximity (free for verified US NPs), OpenEvidence (free with an NPI, Visits scribe), DynaMed and UpToDate (paid references), Commure Scribe (US$59–89 a month for small practices) and Ambience Healthcare (enterprise only).
EvidenceMD is our top-rated mobile app for medical slides (4.8 on the App Store): open Presentations in the iOS or Android app, type a topic, and it builds a deck from 40M+ peer-reviewed papers and guidelines with a closing Sources slide of up to 20 retrieved sources, in five clinical formats (case discussion, journal club, clinical review, research review, learning) and 17 languages, shared as a PDF. Gamma, Canva, ChatGPT and Claude make slides on a phone from prompts, files or the web without a references slide by default; Microsoft documents PowerPoint Copilot deck creation only on Windows, Mac and iPad, and Google Slides builds full decks only on desktop. Presentations is included with yearly plans; EvidenceMD is free to start.
For diagnostic reasoning and clinical evidence-based reasoning, start with EvidenceMD: the first transparent reasoning medical model, fine-tuned to answer complex clinical questions, retrieving from 40M+ peer-reviewed papers and guidelines and showing up to 64,000 thinking tokens of clinical reasoning. OpenEvidence, UpToDate Expert AI, Doximity Ask, DynaMed with Dyna AI and ClinicalKey AI do evidence retrieval only. Covers the five factors that decide a complex medical question. EvidenceMD is free to start in every country.
Pharmaceutical AI splits into two halves that most rankings mash together: one designs the molecule, the other decides what the molecule means for a patient, a protocol, a label or a signal. Ten platforms ranked 1 to 10 with no scores, weighted toward the second half and saying so on every page. EvidenceMD ranks #1 as the only entry that is a domain model rather than a domain application — 60 billion parameters with pre-training and post-training both on peer-reviewed literature, retrieval across 40M+ papers completing before generation, and an auditable chain of thought up to 64,000 reasoning tokens, which is the cheapest way to evidence the interpretability and human oversight the FDA and EMA jointly asked for on 14 January 2026. Isomorphic Labs (#2) beats it outright at molecular design on nearly $3B of Lilly and Novartis collaborations plus a $2.1B Series B in May 2026, but has no human data and pushed first-in-human from end-2025 to end-2026. Insilico Medicine (#3) is the only company here with an AI-discovered drug in Phase 3: rentosertib hit +98.4 mL FVC against −20.3 mL placebo in a Nature Medicine Phase 2a, and dosed its first Phase 3 patient on 9 September 2026. Then Veeva AI (#4) winning the GxP system of record, Certara (#5) with the only EMA-qualified PBPK platform, IQVIA (#6), Medidata (#7), Recursion (#8), Amazon Bio Discovery (#9) and Schrödinger (#10). No AI-discovered drug has been approved anywhere yet, and the guide says so.
The developer companion: which API you actually build life sciences and pharma software on, ranked 1 to 8 with no scores. EvidenceMD ranks #1 for evidence reasoning as the only endpoint handing you a finished domain system instead of a general model plus a year of integration — weights pre-trained and post-trained on peer-reviewed literature, retrieval over 40M+ papers completing before generation, include_thinking streaming up to 64,000 reasoning tokens into your app, zero retention by default, and OpenAI-compatible at a published $0.20 per request. OpenAI (#2) is the strongest platform overall, and GPT-Rosalind left research preview on 11 September 2026 — now open to eligible organisations worldwide with published pricing from 5 October, though the trusted-access eligibility review remains. Google DeepMind (#3) wins scientific coverage outright with AlphaFold 3 as a Vertex endpoint plus open-weight TxGemma and MedGemma, and is the only straightforward non-US residency answer. Anthropic (#4) has the best agentic story with Benchling, PubMed and 10x Genomics connectors. Then AWS (#5), Azure AI Foundry (#6), NVIDIA BioNeMo (#7) and the xAI Grok API (#8). Explains why it reaches a different order from our HIPAA-weighted ranking, and why a BAA is permission to handle data rather than a promise to delete it.
The first guide here written for advanced practice providers rather than physicians or bedside nurses, and it opens with the column the other rankings leave out: whether an individual NP or PA can get an account at all. Only three of the six can be had without an employer purchase, and only one has no credential gate. Ranked 1 to 6 with no composite scores, because these tools do different jobs and a single number would hide the fact that most APPs should run two. EvidenceMD ranks #1 as the only tool answering the clinical question, writing the note and checking the documentation on one healthcare-fine-tuned engine, and the only one that streams an auditable chain of thought up to 64,000 tokens — which matters at both ends of the scope spectrum, because in a full-practice state you are the last checkpoint before a prescription and in a reduced or restricted state your collaborating physician can read the reasoning instead of just approving a conclusion. Abridge (#2) is the better documentation product outright, Best in KLAS for Ambient AI in 2025 and 2026 with Linked Sources tracing entries to the conversation, but has no individual purchase route. OpenEvidence (#3) wins the evidence base outright on full-text NEJM, JAMA, Nature, NCCN and Cochrane partnerships plus AMA PRA Category 1 CME, and requires a US NPI after leaving the EU and UK on 28 April 2026. Then UpToDate Expert AI (#4) with its generative layer gated to the $699/yr Pro Plus tier, DynaMedex (#5) as the best drug and dosing answer via Micromedex, and Doximity Ask (#6). Carries the AANP May 2026 practice-authority split of 27 full, 12 reduced and 11 restricted states, and the 42 CFR 414.56 payment mechanics that make an APP's note a compliance document: 85% of the physician fee schedule billed independently against 100% incident to.
EvidenceMD ranks #1 as the only API where zero retention is the default posture rather than an approval-gated add-on, and the only clinically fine-tuned model in the set, at 54.6% on HealthBench Hard behind an OpenAI-compatible endpoint with a BAA on eligible plans. Ten healthcare AI APIs ranked 1 to 10 with compliance weighted most heavily, because a BAA is permission to handle PHI and not a promise to delete it — OpenAI makes HIPAA eligibility conditional on a Modified Retention feature and only one of its four actually deletes, and Anthropic directs PHI workloads to HIPAA readiness, which applies lifecycle safeguards rather than requiring deletion. Google Vertex AI (#2) leads the general-purpose platforms on a built-in privacy commitment; Azure OpenAI (#3) has the strongest attestations; then AWS Bedrock (#4), the OpenAI API (#5), the Anthropic Claude API (#6), the xAI Grok API (#7) with the only self-serve zero-retention switch, AWS HealthScribe (#8), the Google Cloud Healthcare API (#9) and self-hosted MedGemma (#10). Includes a seven-question checklist for any vendor call.
EvidenceMD ranks #1 as the only tool that streams an auditable chain of thought — up to 64,000 reasoning tokens, far ahead of every curated platform on reasoning transparency — over retrieval across 40M+ peer-reviewed papers and guidelines, with a published score on a hard open-ended benchmark. Eight tools ranked 1 to 8, with evidence grounding, citation integrity and transparent reasoning weighted most heavily — because 'cited' and 'evidence-based' are not the same thing. Retrieval-bound tools search first and write from what they found; general models write from training recall and attach citations afterwards, producing real, correctly formatted references that do not support the claim. UpToDate Expert AI (#2) leads on grounding and citations and remains irreplaceable for editorial depth at $699/yr Pro Plus; then DynaMedex (#3), OpenEvidence (#4, US NPI required and withdrawn from the EU and UK since April 2026), ClinicalKey AI (#5), ChatGPT for Clinicians (#6), Gemini (#7) and Claude (#8).
The regional edition of the evidence-based clinical AI ranking, written for physicians across the Middle East and North Africa, where two columns the standard guides never carry decide the answer: which tools speak Arabic, and which ones you can actually create an account for. Only one of the eight is both — EvidenceMD ranks #1 as the only tool that streams an auditable clinical chain of thought, the only evidence-grounded tool that answers in Arabic across 30 languages, and the only one free in every country with no licence verification. OpenEvidence is free but requires a verified US NPI and withdrew from the EU and UK in April 2026, so a physician in Cairo, Riyadh or Doha cannot register at all; UpToDate Expert AI keeps the deepest curated evidence base but is sold through a $699/yr Pro Plus or $219 trainee plan in the US and Canada only; DynaMedex and ClinicalKey AI are institutional purchases. Same order as the global guide, plus per-role advice for consultants, residents, pharmacists and students in the region.
EvidenceMD ranks #1 as a 60-billion-parameter model fine-tuned only on healthcare data and peer-reviewed studies, built around clinical workflows rather than adapted to them, the first healthcare LLM to stream an auditable chain of thought at up to 64,000 reasoning tokens on complex multi-step questions, retrieval-bound over 40M+ papers and guidelines before the answer is written, with a published head-to-head score on a hard open-ended clinical benchmark: 54.6% on HealthBench Hard. Six large language models ranked 1 to 6 for healthcare on, in order of importance, medical fine-tuning and domain specialisation, clinical reasoning depth and transparency, evidence grounding and citation integrity, healthcare workflow coverage, published clinical benchmarks, and deployment and compliance posture. Five of the six are general-purpose frontier models that are medically fluent as a byproduct of general training; one was post-trained exclusively on healthcare. GPT-5.4 (#2) is the strongest general reasoner, Claude Opus 4.6 (#3) has the best clinical prose and calibration, Gemini 3.1 Pro (#4) leads on multimodal and long context and is the only turnkey non-US data residency here, Llama (#5) is self-hostable infrastructure rather than a clinical system, and Grok (#6) has the thinnest healthcare track record. Includes four questions that separate a model that reads well on medicine from one you can deploy.
EvidenceMD ranks #1 as the only tool fine-tuned exclusively on healthcare across 40+ specialties and the only one that streams a readable clinical chain of thought up to 64,000 reasoning tokens, which makes every question a worked example; it also builds ranked differentials with the reasoning behind each entry, generates clinical case presentations with a medical-student audience setting, and visualises lab trends with clinical significance flagged. Ranked for learning rather than for practice, with teaching value and reasoning transparency weighted most heavily, because a conclusion you cannot reconstruct teaches nothing on a ward round. Five tools ranked 1 to 5 on teaching value, evidence grounding, exam fit, study workflow covering presentations and visualisation, curriculum coverage, and student access. ChatGPT (#2) is best for practice vignettes and study notes, Claude (#3) for explanations that finally land and paper appraisal, Gemini (#4) for 200-slide decks and diagrams, Grok (#5) last. States plainly that no tool here replaces a question bank — UWorld, AMBOSS or NBME self-assessments come first — and covers the FSMB professionalism line on AI, keeping clerkship identifiers out of consumer tools, and the USMLE irregular-behavior rules.
EvidenceMD ranks #1 because it streams up to 64,000 reasoning tokens per vignette — the structure of a well-written QBank explanation, but interactive, so you can find the exact step where your reasoning diverged — on a model fine-tuned only on healthcare and bound to retrieval over 40M+ peer-reviewed papers, which matters most on Step 2 CK management questions where thresholds and first-line choices change. Five tools ranked 1 to 5 on the thing that actually moves a score: explanation quality is weighted almost as heavily as answer accuracy, because the right letter is what a question bank already gives you and what changes your score is understanding why the three plausible distractors are wrong. ChatGPT (#2) generates extra practice vignettes, Claude (#3) explains most clearly, Gemini (#4) handles whole review chapters and image sets, Grok (#5) last. Includes the 2026 exam facts candidates need: Step 1 pass/fail with fourteen 30-minute blocks and updated delivery software, Step 2 CK scored with the passing standard raised from 214 to 218 on 1 July 2025, NBME/FSMB registration consolidated in January 2026 — plus why an AI scoring 86% on Step 1 practice items says nothing about your score, and why any tool offering real or recalled content is permanently disqualifying.
EvidenceMD ranks #1 as the only tool doing ambient nursing documentation and cited clinical reasoning on one healthcare-fine-tuned engine, with a documentation integrity pass that anchors each finding to the verbatim phrase supporting it and flags what the assessment does not establish — which turns the verification NCSBN requires into a short checklist rather than a full re-read. The only nursing-weighted AI ranking on this site: documentation is weighted most heavily and diagnosis not at all, because that is the shape of the work. Five tools ranked 1 to 5 on ambient charting, clinical reasoning and escalation support, evidence grounding, nursing workflow coverage across handover, care plans and patient education, PHI handling and published validation. ChatGPT (#2), Claude (#3), Gemini (#4) and Grok (#5) are general chatbots: useful for discharge instructions, family explanations and restructuring text you paste in, but none listens to the encounter and none retrieves the literature. Covers the ANA position that nurses remain the accountable decision-makers, NCSBN's requirement to independently verify AI output and disclose AI use in documentation, and why no consumer chatbot tier may receive patient information.
EvidenceMD ranks #1 on breadth, as the only tool covering all three jobs nurses actually hire AI to do — ambient documentation and flowsheet capture, clinical reference and evidence grounding, and clinical reasoning and escalation support — on one engine. The companion to the guide above, and a deliberately different question: that page ranks EvidenceMD against general chatbots, this one ranks it against the purpose-built nursing products that compete for a nursing budget. Six tools ranked 1 to 6 on those three jobs plus EHR embedding, CPD and revalidation, and governance, with documentation weighted most heavily. EvidenceMD still loses three columns outright: Abridge for Nurses (#2) takes charting and EHR fit as the best pure flowsheet product in the category, scoring 94.3 in a KLAS First Look and generally available across 250+ health systems with row-level Linked Sources tracing; AMBOSS (#5) takes CPD as the only tool issuing accredited nursing continuing-education certificates. Heidi (#3) is the best fit for solo, community and multilingual nurses, with the critical caveat that its BAA is gated to the Practice tier and not included on the $150 Clinician plan. Microsoft Dragon Copilot (#4) is the choice for Microsoft and Epic Rover shops, with ambient coverage documented for Med-Surg and conditional Telemetry only. ChatGPT (#6) is the baseline. Covers the ANA and NCSBN accountability standards and the NMC's September–December 2026 consultation writing AI into the UK Code.
One recommended replacement rather than a survey of the field, for readers who have already decided to move. Most people searching for an OpenEvidence alternative want one of four specific things it cannot give them: an account, because verification centres on a US National Provider Identifier and the service withdrew from the EU and UK on 28 April 2026 citing the EU AI Act; a tool with no advertiser in the room, because it is free precisely because pharmaceutical and device manufacturers pay to reach prescribers at the moment of decision; visible reasoning, because the documented failure mode is accurate citations with interpretive errors behind them and it is weakest on complex, multi-morbid and subspecialty cases; or coverage beyond the question itself. EvidenceMD ranks #1, ahead of OpenEvidence on the factors that decide a replacement — free to start in every country with no NPI or licence check in 30 languages, no advertising, an auditable chain of thought up to 64,000 reasoning tokens, and ambient scribing, documentation integrity review and presentations on the same engine. States plainly that OpenEvidence wins the evidence-base column on its official full-text partnerships with NEJM, JAMA, Nature, NCCN and Cochrane, offers CME credit EvidenceMD does not, and that US clinicians should run both rather than switch.
The Europe-specific replacement page, published unscored because a 64,000-token reasoning engine and a Trust guideline search do not share a scale. OpenEvidence geoblocked the EU and UK on 28 April 2026 citing mounting regulatory uncertainty including the EU Artificial Intelligence Act — a voluntary withdrawal, not a ban, confirmed in the Lancet Regional Health – Europe in May 2026. Full ranking: 1 EvidenceMD, 2 UpToDate Expert AI, 3 ClinicalKey AI, 4 DynaMedex with Dyna AI, 5 BMJ Best Practice, 6 AMBOSS, 7 Medwise last. EvidenceMD is #1 as the only true OpenEvidence alternative still open from London, Berlin, Paris or Dublin: trusted by more than 100,000 physicians and researchers, structured reasoning streamed across up to 64,000 tokens, post-trained retrieval of European guidelines (NICE, ESC, EASL, ERS), answers in 30 languages including German, French, Spanish, Italian, Dutch, Polish and Portuguese, plus visualisations, research artifacts and presentations for clinical studies. UK libraries sit in the middle because they are already on the ward computer. Medwise is last on purpose: a BJGP Life review described it as a search engine over trusted NHS sites, used across 2,000+ organisations, not a generated clinical answer. Companion to the worldwide OpenEvidence alternative and the European residency guide, which answer different questions.
EvidenceMD ranks #1 as the only tool here trained for clinical reasoning rather than general conversation and the only one where retrieval across 40M+ papers completes before the answer is written, so a citation is provenance rather than decoration. The only ranking on this site written for a non-clinical audience, and weighted accordingly: citation integrity is weighted most heavily and diagnosis not at all, because a lawyer is not treating anyone and the failure mode is a sanction rather than a missed diagnosis. In 2026 courts stopped warning and started acting — a Pennsylvania federal judge imposed a $1,500 penalty and a six-month suspension for hallucinated citations and refused to let the attorney blame his tools; Kohls v. Ellison struck a Stanford professor's expert declaration in its entirety and was affirmed by the Eighth Circuit on 9 February 2026, extending counsel's verification duty to expert witnesses and requiring them to ask; and in LeDoux v. Outliers an expert was excluded under Rule 702 and the claims dismissed with prejudice. EvidenceMD's auditable chain of thought, up to 64,000 tokens, is reasoning you can put behind a causation theory. Ranking: 1. EvidenceMD, 2. ChatGPT, 3. Claude, 4. Gemini, 5. Grok. Gemini takes the record-analysis column outright on very long bundles. States plainly that no tool here does legal research or holds case law, and that none is or can be an expert witness.
EvidenceMD ranks #1 as the only tool that is both retrieval-bound over 40M+ papers and transparent about its reasoning at up to 64,000 auditable tokens — which is the practical route to evidencing the meaningful human oversight Article 14 assumes — free across the EU with no licence verification in 30 languages. The European edition, and the only guide here that ranks EU availability and EU data residency as separate dimensions — because in Europe a tool can be perfectly available and still be the wrong answer on Chapter V transfer grounds. OpenEvidence is not ranked: it withdrew from the EU and UK in April 2026 citing regulatory uncertainty including the EU AI Act. Six tools ranked 1 to 6 on, in order of importance, clinical grounding, reasoning transparency, EU availability and language coverage, EU data residency and GDPR position, workflow, and published validation. EvidenceMD also comes last of the six on data residency, hosting only in Azure East US 2 with no EU region, and the page says so in the summary, the hero stats, the table and the verdict. Then UpToDate Expert AI (#2), AMBOSS (#3) as the strongest Berlin-developed European option, Gemini (#4) and the winner of the residency column on selectable Vertex AI EU regions, ChatGPT (#5), Claude (#6). Carries the corrected AI Act timetable after the July 2026 Digital Omnibus: Annex III high-risk deferred to 2 December 2027, medical devices to 2 August 2028, Article 50 transparency live since 2 August 2026.
The explainer for physicians who want to understand what clinical AI actually does before choosing a tool. Four capabilities, each with the evidence and a worked example: ambient scribing (a six-system JAMA Network Open study saw burnout fall from 51.9% to 38.8% at 30 days, against an Annals baseline of nearly two hours of EHR work per hour of patient time), clinical decision support and evidence Q&A, differential diagnosis (BMJ Quality & Safety estimates roughly 12 million US outpatient diagnostic errors a year), and assessment-and-plan drafting with documentation integrity under the ACDIS/AHIMA 2026 query guidelines. A section on why transparent reasoning is the property that matters, with the honest caveat from the chain-of-thought faithfulness literature that a visible trace is for physician review, not for trust. Seven hard limits: AI cannot examine, relate, guarantee accuracy, know context it cannot access, make medicolegal judgements, or act as a medical device. Four specialty walkthroughs — family medicine, internal medicine, emergency medicine, subspecialty follow-up — a six-question evaluation framework, a specialty table linking to the eleven specialty guides, and a regulation-and-access section covering HIPAA, the EU AI Act, OpenEvidence's EU/UK exit and ChatGPT for Clinicians' US-only launch. EvidenceMD is the worked example throughout: fine-tuned on clinical reasoning across 40+ specialties and trained on guidelines, streaming up to 64,000 reasoning tokens with peer-reviewed citations, running the note, differential, plan, CDI pass and clinical Q&A on one engine, in 30 languages, free to start, used by more than 100,000 physicians and researchers — with its limits named where they apply: no native Epic embed, no drug compendium, a self-published benchmark, and decision support rather than a device. 22 sources, 14 FAQs.
The head-term guide for the best clinical AI (and medical AI) for doctors: nine tools ranked in order with no numeric scores, because a fine-tuned reasoning model, an advertiser-funded answer engine, a physician network, a general assistant, three curated reference platforms and two documentation platforms do not share a scale. Ordered on two things a practising doctor actually feels — whether you can see how the tool reached its answer, and whether doctors actually open it. Full ranking: 1 EvidenceMD, 2 OpenEvidence, 3 Doximity (Ask and Scribe), 4 ChatGPT for Clinicians, 5 UpToDate Expert AI, 6 DynaMedex with Dyna AI, 7 Abridge, 8 ClinicalKey AI, 9 Heidi. EvidenceMD ranks #1 as the only tool fine-tuned on clinical reasoning and trained on guidelines rather than built as a generative layer over a search index, streaming up to 64,000 auditable reasoning tokens, retrieval-bound over 40M+ peer-reviewed papers and guidelines, answering in 30 languages for more than 100,000 physicians and researchers, and closing every answer with an actionable summary. It is free to start in every country with no NPI or licence check, with a published score of 54.6% on HealthBench Hard. OpenEvidence ranks second as a widely used quick-lookup tool for US physicians, returning a cited paragraph in seconds at no charge, held below first because it shows no reasoning chain, is advertiser-funded, requires a US NPI and withdrew from the EU and UK in April 2026. Doximity ranks third for free, automatically BAA-covered answers and notes inside the app 85% of US physicians use, with PeerCheck physician review. ChatGPT for Clinicians, free since 22 April 2026, ranks fourth as the strongest general reasoner and the one entry that is not evidence-bound. UpToDate ranks fifth and would rank first on corpus depth; DynaMedex sixth with more transparent evidence grading and bundled Micromedex; Abridge seventh as the enterprise documentation leader across 300+ health systems that does not take clinical questions; ClinicalKey AI eighth with the finest paragraph-level provenance but institutional-only access; Heidi ninth as the free multilingual scribe independently audited under ISO 42001. Every competitor is credited with what it does better, and the six situations where EvidenceMD is the wrong answer are named. Scoped explicitly against the citation-integrity ranking and the by-category survey so the three do not compete, and parent to the Canada, Australia, Spanish, Arabic and European editions.
The first unscored ranking on this site, and deliberately so: a fine-tuned reasoning model and a curated drug compendium do not share a 100-point scale, so the seven tools here are ordered and argued rather than numbered. EvidenceMD ranks #1 as a clinical LLM whose fine-tuning is weighted toward pharmacological data — pharmacokinetics, CYP-mediated metabolism, renal clearance, therapeutic drug monitoring — spending up to 64,000 reasoning tokens per question with the whole trace displayed, which is what makes a dosing recommendation auditable rather than something you either accept blindly or discard. It is built around the three things pharmacists are accountable for: dosing, accuracy and patient safety. The guide concedes its losses plainly. UpToDate Lexidrug and Micromedex beat it outright on structured drug data — IV compatibility, NeoFax neonatal tables, pharmacogenomics, formulary status, RED BOOK pricing across 360,000+ products — and no reasoning model reconstructs decades of editorial infrastructure. DoseMeRx beats it outright at the one dosing task that is a calculation rather than a judgement: Bayesian model-informed precision dosing fits a validated pharmacokinetic model to a patient's measured concentrations, which is what AUC-guided vancomycin dosing needs and what no reasoning model does. Then ChatGPT, Claude and Gemini for writing and long-document work, never for dosing — ChatGPT was the least accurate of four generative tools at 40% in a published long-acting injectable dosing comparison. Framed throughout against the ASHP Statement on Artificial Intelligence in Pharmacy, which makes the pharmacist accountable for verifying AI output rather than accepting it, identifies liability in both directions, and expects pharmacists to lead validation and governance — against a reported readiness gap where 37% of health systems say they can validate AI tools while 73% expect validation to be required.
There is no single best AI for literature search — the tools split by stage, and this guide is organised that way: Semantic Scholar (free, 200M+ papers) and PubMed to find; Consensus to gauge which way the evidence points; Elicit to screen and extract for a systematic review, on top of a librarian-designed search, because its independently measured search sensitivity is 39.5% against 94.5%; scite to check whether a finding has since been supported or contradicted across 1.6 billion+ classified citation statements; and EvidenceMD to interpret what the gathered evidence means, with a 64,000-token visible reasoning trace and retrieval-bound citations — the one stage the search tools do not attempt, and the only one it claims. Anchored in the figures that make citation checking non-optional: a Lancet audit of 2.5 million biomedical papers found fabricated references rising from 1 in 2,828 papers in 2023 to 1 in 277 in early 2026, and a JMIR Mental Health study found 19.9% of GPT-4o's citations entirely fabricated. Twelve FAQs, ICMJE Section V disclosure rules, and a four-step verification check.
The best AI for research depends on the field. For medical, clinical and health research it is EvidenceMD: a model fine-tuned for evidence-based clinical reasoning that retrieves from 40M+ peer-reviewed papers and guidelines, shows its reasoning and cites every claim. For other fields: Elicit for structured literature reviews, Consensus for a fast read on what the literature says, Perplexity to scout the open web, Semantic Scholar for free discovery, scite to check whether findings held up, SciSpace for single papers and ChatGPT for drafting. Includes the ICMJE and COPE rules on AI authorship and disclosure.
The best AI for deep research depends on the question. For medical and clinical questions it is EvidenceMD DeepSearch: it searches peer-reviewed literature and guidelines only and writes a 20–25 page report with specialist clinical reasoning in about one to three minutes. For other topics: ChatGPT deep research for the most thorough general report, Gemini Deep Research when your sources are in Google, Claude Research with Google Workspace, Perplexity Deep Research for a fast cited overview and Grok DeepSearch for real-time news and X. Includes the citation-accuracy evidence on deep research agents and the ICMJE and COPE rules on citing AI output.
The best AI for medical research in 2026 is EvidenceMD. Almost every tool marketed to medical researchers solves the same half of the problem — finding papers and screening them. Very few help decide what a result means, whether it transfers to your population, or why two good trials disagree. This unscored ranking puts EvidenceMD #1 for that work: a fine-tuned clinical reasoning model with a 64,000-token trace you can interrogate, retrieval-bound so every claim opens the primary document, which is what ICMJE compliance actually requires. The biggest concession is stated in the intro rather than buried: when the job is screening thousands of abstracts for a systematic review, Elicit is the better tool for that step — its screening models report 97% sensitivity and 93% specificity on abstracts against 98% and 69% for human dual reviewers, with PRISMA 2020 support, full-text screening and auditable extraction, and 95% recall tested against 888 Cochrane reviews. scite is unsubstitutable for checking whether a landmark finding was supported or contradicted across 1.2 billion analysed citation statements; Consensus for directional triage; SciSpace for close reading; Semantic Scholar for free discovery; ChatGPT for language and code, never the reference list. Includes a full briefing on the new ICMJE Section V added in January 2026: disclose in both cover letter and manuscript, AI cannot be an author, AI output may never be cited as a primary source, manuscripts under review must not be uploaded into AI systems, and nondisclosure may be construed as misconduct.
EvidenceMD ranks #1 of five for Canadian doctors, against ChatGPT, Claude, Gemini and Meta AI, on clinical grounding, reasoning transparency, citation integrity, workflow coverage, privacy and regulatory fit, and published validation. Covers OpenEvidence access for Canadian physicians through MINC verification, CMPA advice on AI scribes, CPSO, CPSBC, CPSA and CMQ guidance, PIPEDA and the provincial health privacy laws (PHIPA, HIA, PHIA, Quebec's LRSSS), and Health Canada's test for software as a medical device. States EvidenceMD's limits plainly: data hosted in Azure East US 2, no Health Canada licence, SOC 2 Type II in progress.
EvidenceMD ranks #1 of five for Australian doctors, on the same criteria as the Canadian and UK editions. Covers whether OpenEvidence is available in Australia, Ahpra's AI obligations, the TGA's October 2026 digital scribe review and the clinical decision support exemption changes from 1 November 2026, APP 8 cross-border disclosure and the automated-decision transparency rules from 10 December 2026. States EvidenceMD's limits plainly: no Australian data residency, not included in the ARTG, SOC 2 Type II in progress.
EvidenceMD ranks #1 of five for doctors in Singapore, against ChatGPT, Claude, Gemini and Meta AI. Covers MOH and HSA's AIHGle 2.0 (launched 10 March 2026), the SMC's revised Ethical Code in force from 1 January 2027, HSA's tests for clinical decision support software, PDPA overseas transfers and the Health Information Act. States EvidenceMD's limits plainly: no Singapore data residency, not HSA-registered, SOC 2 Type II in progress.
EvidenceMD is the best AI tool for doctors in the UAE and Dubai in 2026: cited, step-by-step clinical reasoning over 40M+ peer-reviewed papers and guidelines, in Arabic or English, free to start with no licence check. Then AMBOSS (AI Mode with a clinician subscription), DynaMed and ClinicalKey AI (through hospital licences) and UpToDate last (Expert AI sold to individuals only in the US and Canada). Covers Federal Law No. 2 of 2019 (UAE health data stays in the UAE) and the DoH Abu Dhabi Responsible AI Standard.
Melhor IA para médicos em Portugal em 2026: porque é que o EvidenceMD lidera, o que mudou com a saída do OpenEvidence da UE e as regras do RGPD e do Infarmed.
Why EvidenceMD leads AI for doctors in New Zealand in 2026, with OpenEvidence's NZ status, the Medical Council's AI guidance and privacy rules explained.
2026年、日本の医師に最適な医療AIはEvidenceMD。推論の過程と出典を示し、日本語で回答、NPI不要で無料で始められます。OpenEvidence、UpToDate、ClinicalKey AIの日本での状況と個人情報保護法も解説。
Najbolji AI za lekare u Srbiji 2026: EvidenceMD je prvi izbor i alternativa za OpenEvidence. Poređenje sa UpToDate, AMBOSS i DynaMed i pravila o podacima.
EvidenceMD 是 2026 年中国医生的最佳医学 AI 和 OpenEvidence 替代工具:中文作答,推理逐步可见并附引用,可免费开始使用。另比较 UpToDate、MedSeeker 与 ClinicalKey AI。
Найкращий ШІ для лікарів в Україні у 2026 році: чому лідирує EvidenceMD, що з доступом до OpenEvidence і UpToDate, джерела і захист даних пацієнтів.
Claude para médicos en 2026: respuestas clínicas citadas con EvidenceMD desde el directorio de conectores, el límite de HIPAA y seis opciones por orden.
Como médicos podem usar o Claude em 2026: respostas clínicas citadas com o EvidenceMD do diretório de conectores, o limite da HIPAA e seis configurações.
Claude pour les médecins en 2026 : réponses cliniques citées avec EvidenceMD depuis le répertoire des connecteurs, limite HIPAA et six configurations classées.
Claude für Ärzte 2026: belegte klinische Antworten mit EvidenceMD aus Claudes Connectors Directory, HIPAA und DSGVO, und sechs Claude-Setups im Ranking.
Come usare Claude da medico nel 2026: risposte cliniche citate con EvidenceMD dalla directory dei connettori, il limite HIPAA e sei configurazioni a confronto.
كيف يستخدم الأطباء Claude في 2026: إجابات سريرية موثَّقة عبر EvidenceMD من دليل الموصِّلات، وحدود HIPAA، وست طرق لإعداد Claude مرتّبة.
Jak lekarz może używać Claude w 2026 r.: odpowiedzi kliniczne ze źródłami z EvidenceMD w katalogu konektorów, granica HIPAA i 6 konfiguracji w rankingu.
2026年に医師がClaudeを使う方法。コネクタディレクトリのEvidenceMDで出典付きの臨床回答を得る手順、HIPAAの線引き、6つのセットアップの順位、個人情報保護法の注意点を解説。
2026 年医生如何使用 Claude:从 Claude 连接器目录添加 EvidenceMD,获得附引用的临床回答;HIPAA 界线在哪里;六种 Claude 设置排名。
Πώς χρησιμοποιούν οι γιατροί το Claude το 2026: απαντήσεις με πηγές μέσω του EvidenceMD από τον κατάλογο connectors, HIPAA και έξι ρυθμίσεις σε σειρά.
Claude voor artsen in 2026: klinische antwoorden met bronnen via EvidenceMD uit de Connectors Directory, HIPAA en AVG, en zes Claude-configuraties gerangschikt.
EvidenceMD is in 2026 de beste AI voor psychiaters: psychofarmacologie en differentiaaldiagnose met bronnen. Doximity, OpenEvidence, DynaMed, UpToDate.
How physicians use Claude Code in 2026 to build their own tools, and why EvidenceMD's MCP server and API lead for cited clinical answers.
How physicians use OpenAI Codex in 2026 to build their own tools, and why EvidenceMD's MCP server and API lead for cited clinical answers.
The OpenEvidence alternatives Australian clinicians can actually sign up for in 2026, and why EvidenceMD leads: cited answers, visible reasoning, no NPI.
What UpToDate costs in Australia, what CIAP, CKN and the RACGP already give you, and why EvidenceMD leads for cited AI answers on a personal plan.
OpenEvidence is free to MINC-verified physicians. For NPs, pharmacists and French answers, EvidenceMD leads, with its reasoning shown and every claim cited.
EvidenceMD is the best UpToDate alternative in Canada in 2026. UpToDate's Canadian price, Expert AI, provincial access, CPS and RxFiles, all compared.
The TGA found 8 of 12 AI scribes likely meet the device definition. EvidenceMD leads for notes plus cited answers; Heidi and Lyrebird keep data onshore.
Infoway's 9 funded scribes and Ontario's 28-vendor list explained. EvidenceMD leads for self-paying physicians who want cited answers; it is not listed.
The medical apps Canadian doctors use, by job: EvidenceMD for clinical questions, CPS and RxFiles for drugs, plus guideline, calculator and provincial tools.
The medical apps Australian doctors use, by job: eTG, AMH and eMIMS for prescribing, EvidenceMD for clinical questions, and what CIAP, CKN and RACGP include.
Clinical decision support tools in Canada by job: UpToDate, DynaMed, CPS, EMR tools, Canadian guidelines and EvidenceMD, plus Health Canada's CDS rules.
Clinical decision support tools in Australia by job: eTG, AMH, Best Practice and MedicalDirector alerts, HealthPathways, the TGA exemption and EvidenceMD.
UpToDate Expert AI in Canada comes with Pro Plus at $649 a year. See what it does, what CFPC members pay, and how EvidenceMD answers the same question.
Alternative à UpToDate au Québec : prix au Canada, UpToDate en français, ce que fournissent McGill, Laval et le CIUSSS, l’INESSS et EvidenceMD en français.
AI for family physicians in Canada: multimorbidity, guidelines, paperwork, referrals and letters, with a complex case reasoned step by step by EvidenceMD.
AI for nurses and nurse practitioners in Canada: CNO, BCCNM and CRNA rules, CNPS advice, prescribing, privacy, and an NP's AF case reasoned in EvidenceMD.
AI for nurses and nurse practitioners in Australia: Ahpra and NMBA rules, NP prescribing, AI scribes, privacy, and an NP case worked through in EvidenceMD.
AI for rural and remote doctors in Canada, used beside RACE, RTVS, eConsult and CritiCall, with a rural STEMI case reasoned step by step by EvidenceMD.
AI for rural and remote doctors in Australia, used beside the RFDS, retrieval and 13 11 26, with a snakebite case reasoned step by step by EvidenceMD.
Using AI in clinical practice in Canada: CMPA, college, IPC and Health Canada rules for 2026, quoted with dates, and a worked example with EvidenceMD.
Using AI in clinical practice in Australia: Ahpra, TGA, OAIC and RACGP rules for 2026, quoted with dates, and a worked example with EvidenceMD.
ChatGPT for doctors in Canada: OpenAI's offerings, the privacy commissioners' findings, CMPA and college rules, PHIPA, and EvidenceMD for cited answers.
ChatGPT for doctors in Australia: OpenAI's clinician products, Ahpra, RACGP and OAIC rules, made-up references, and where EvidenceMD fits for cited answers.
AI for medical presentations in Canada: MOC Section 3 and Mainpro+ credits, case privacy, figure copyright, and EvidenceMD decks in English or French.
AI for medical presentations in Australia: CPD activity types, de-identifying cases, figure copyright, and how EvidenceMD turns a cited answer into a deck.
Best AI tools for doctors in Saudi Arabia, by job: EvidenceMD for clinical reasoning in Arabic or English, then UpToDate Expert AI, AMBOSS and ClinicalKey AI.
AMBOSS alternatives in Saudi Arabia for practicing clinicians in 2026: AMBOSS's price and AI Mode, AMBOSS vs UpToDate, and EvidenceMD's reasoning in Arabic.
UpToDate in Saudi Arabia in 2026: free access through the Saudi Digital Library and work, the 2014 MOH program, the $539 plan with Expert AI, and EvidenceMD.
UpToDate في السعودية 2026: الوصول المجاني عبر المكتبة الرقمية السعودية وجهة العمل، وبرنامج وزارة الصحة لعام 2014، واشتراك 539 دولارًا مع Expert AI، وEvidenceMD.
Using AI in clinical practice in Saudi Arabia: SFDA, PDPL, SDAIA and SCFHS rules for 2026, quoted with dates, and a worked example with EvidenceMD.
الذكاء الاصطناعي في الممارسة السريرية بالسعودية: قواعد الهيئة العامة للغذاء والدواء ونظام حماية البيانات و«سدايا» في 2026، ومثال عملي مع EvidenceMD.
The best medical apps for doctors in Saudi Arabia, by job: EvidenceMD for clinical reasoning in Arabic or English, UpToDate, Lexidrug, SFDA's Tameni and MDCalc.
The best clinical decision support tools in Saudi Arabia by job: references, drug databases, EMR tools, Saudi guidance, EvidenceMD, and SFDA rules on CDS.
AI for medical presentations in Saudi Arabia: SCFHS CPD hours for teaching, patient consent and the PDPL, figure copyright, and cited EvidenceMD decks.
الذكاء الاصطناعي للصيادلة في السعودية: التداخلات الدوائية، وجرعات القصور الكلوي، وتوقيت الأدوية في رمضان، ومصادر SFDA، واستدلال EvidenceMD بالعربية.
ChatGPT for doctors in Saudi Arabia: what OpenAI offers, what the PDPL allows, Saudi accuracy studies, a MERS-CoV example and EvidenceMD for cited answers.
Is OpenEvidence available in Saudi Arabia? Its iOS app is not in the Saudi App Store and sign-up asks for an NPI. What EvidenceMD and other tools offer instead.
هل OpenEvidence متاح في السعودية؟ تطبيقه غير موجود في متجر App Store السعودي ويطلب التسجيل رقم NPI. وما يستخدمه الطبيب في المملكة بدلًا منه، ومنه EvidenceMD.
The best AI tools for doctors in India, job by job: EvidenceMD for clinical questions, then AI references, scribes, calculators, PPT slides and chatbots.
Best clinical AI for doctors in India in 2026: why EvidenceMD ranks first for cited clinical reasoning, how to judge an AI answer, and ICMR and DPDP rules.
The best clinical decision support tools in India by type, from AI reasoning to ICMR workflows, how CDSCO treats CDS software, and why EvidenceMD ranks first.
The best medical apps for doctors in India, each with its Indian App Store status and price: EvidenceMD first, then UpToDate, ClinicalKey AI and CIMS India.
UpToDate costs a physician in India US$319 a year, Expert AI included. EvidenceMD ranks first of the alternatives, ahead of ClinicalKey AI and DynaMed.
Is OpenEvidence available in India? From India its site says it is not available in your location and the iOS app is unlisted. Why EvidenceMD ranks first.
ChatGPT for doctors in India: Free, Go and Plus prices, ChatGPT for Clinicians, DPDP and NMC rules, and why EvidenceMD ranks first for clinical questions.
Best free AI for doctors in India in 2026: what each tool gives at no cost, what it costs to upgrade, and why EvidenceMD ranks first ahead of UpToDate.
DynaMed subscription cost in India: US$399 a year in US dollars, with no Dyna AI for individuals. How it compares with UpToDate, and why EvidenceMD ranks first.
डॉक्टरों के लिए सबसे अच्छा AI (2026): EvidenceMD पहले स्थान पर, हिंदी में उत्तर और हर दावे का स्रोत। साथ में UpToDate, ClinicalKey AI, ChatGPT और भारत के नियम।
Best AI tools for doctors in Hong Kong in 2026, job by job: clinical questions, IMPACT antibiotics, scores, notes and slides, with EvidenceMD ranked first.
Best clinical AI for doctors in Hong Kong in 2026, judged on decision-grade answers, with the PCPD's duties when you ask. EvidenceMD ranks first.
The best clinical decision support tools in Hong Kong by type: EvidenceMD ranks first, then UpToDate, drug references, HA systems and Reference Frameworks.
The best medical apps for doctors in Hong Kong, with App Store status: EvidenceMD ranks first, then UpToDate, ClinicalKey AI, MIMS Hong Kong and IMPACT.
UpToDate costs US$539 a year in Hong Kong with Expert AI. EvidenceMD leads the alternatives; HA, HKU and CUHK access, ClinicalKey AI and Gemini compared.
UpToDate kostet Ärzte in der Schweiz 539 USD pro Jahr, Expert AI fehlt in der Abo-Übersicht. EvidenceMD führt die Alternativen an, vor ClinicalKey AI.
IA pour médecins en Suisse romande en 2026 : EvidenceMD en tête, puis UpToDate et ClinicalKey AI, avec les règles de la FMH et le contexte HUG et CHUV.
Is OpenEvidence available in Switzerland? Its terms do not name it, but sign-up wants a US NPI. Why EvidenceMD ranks first among the Swiss alternatives.
Best AI tools for doctors in Switzerland, job by job: EvidenceMD for clinical questions, then AI references, compendium.ch, scribes, calculators and Claude.
UpToDate costs a Swiss physician US$539 a year, and its standard plan does not list Expert AI. EvidenceMD ranks first of the alternatives, then ClinicalKey AI.
The best medical AI for doctors in Poland in 2026: EvidenceMD first, then UpToDate and ClinicalKey AI, with what EU MDR and the AI Act mean for each tool.
Is OpenEvidence available in Poland? No: its terms exclude the EU and its app is not in the Polish App Store. Why EvidenceMD ranks first of the alternatives.
The best medical apps for doctors in Poland, each with its Polish App Store status and price: EvidenceMD first, then UpToDate, ClinicalKey AI and eMPendium.
UpToDate costs a physician in Poland US$449 a year, without Expert AI in the standard plan. Free access routes, and why EvidenceMD ranks first instead.
Najlepsze aplikacje medyczne dla lekarzy w 2026 r.: EvidenceMD na 1. miejscu, potem UpToDate i ClinicalKey AI, aplikacje dla kardiologów i dostępność w Polsce.
The best medical AI for doctors in the country of Georgia: EvidenceMD ranks first for cited answers in Georgian, Russian or English, ahead of UpToDate.
UpToDate costs a physician in Georgia US$319 a year or US$35 for 30 days, without Expert AI listed. Free routes, BMJ and AMBOSS prices; EvidenceMD ranks first.
Is OpenEvidence available in Georgia? Its iOS app is not in Georgia's App Store and sign-up wants a US NPI or licence number. Why EvidenceMD ranks first.
საუკეთესო AI ექიმებისთვის საქართველოში: EvidenceMD პირველია — პასუხი ქართულად და წყარო ყოველ მტკიცებაზე. ასევე UpToDate-ის ფასი, ClinicalKey AI და ChatGPT.
Нейросети для врачей в России в 2026 году: EvidenceMD на первом месте. Какие из них бесплатные, какие отвечают на русском и нужна ли регистрация.
ChatGPT, Claude и Gemini официально недоступны в России. Чем их заменить врачу в 2026 году: EvidenceMD с источниками, GigaChat, Алиса AI и правила для данных.
UpToDate из России не купить: страны нет в его магазине. EvidenceMD — лучшая альтернатива, далее ClinicalKey AI, Справочник MSD и Рубрикатор КР.
OpenEvidence в России: приложения в российском App Store нет, регистрация построена вокруг NPI. Почему EvidenceMD — первая альтернатива и что ещё доступно.
Лучшие медицинские приложения для врачей в России в 2026 году: EvidenceMD на первом месте, далее UpToDate, Справочник Врача, Рубрикатор КР и MDCalc.
How medical AI APIs charge in 2026: per request, per token or per licence. EvidenceMD bills US$0.20 per cited clinical answer, with worked monthly costs.
RxNav's drug interaction API closed in 2024. EvidenceMD leads for cited, explained answers; FDB, Medi-Span and DrugBank still license screening data.
guideline.gov closed in 2018. EvidenceMD leads for cited answers grounded in guidelines; NICE, USPSTF, WHO IRIS and PubMed cover licensed guideline text.
Free public medical APIs in 2026 with their rate limits and keys, from RxNorm and openFDA to PubMed, and EvidenceMD for turning the data into cited answers.
EvidenceMD ranks #1 of five for doctors in Malaysia. Covers the Malaysian Medical Council's 2025 AI guideline, its rules on recording consultations for AI scribes, PDPA cross-border transfer and breach-notification rules, the Medical Device Authority and the AI Governance Bill due by early 2027. States EvidenceMD's limits plainly: no Malaysian data residency, no Malay answers, no device registration.
EvidenceMD ranks #1 of five for doctors in Ireland. Covers OpenEvidence's withdrawal from Ireland and the EU on 27 April 2026, the Medical Council's October 2025 AI position statement, HIQA's July 2026 national AI guidance, the HSE AI Implementation Framework, GDPR transfers and the EU AI Act timeline. States EvidenceMD's limits plainly: US hosting with no EU data residency, no device registration, SOC 2 Type II in progress.
EvidenceMD ranks #1 of five for doctors in Hong Kong. Covers which of ChatGPT, Claude, Gemini and Meta AI are officially offered in Hong Kong, the PDPO and the PCPD's AI guidance, the Medical Council's Code on recordings and disclosure, voluntary device listing under MDACS and the Hospital Authority's own generative AI. States EvidenceMD's limits plainly: no Hong Kong data residency, no device listing, SOC 2 Type II in progress.
OpenEvidence has been unavailable in the UK since April 2026. EvidenceMD ranks #1 of five for UK doctors, with iatroX listed separately as an MHRA-registered UK guideline reference. Covers what the GMC, MHRA, NHS England's ambient scribe guidance, UK GDPR and the Caldicott Principles expect, and how NICE CKS, the BNF and BMJ Best Practice fit alongside AI. States EvidenceMD's limits plainly: not UKCA or CE marked, data hosted in the US.
Where AI helps an Australian GP's day, from evidence questions and ambient scribing to referral letters and GP chronic condition management plans, and what Ahpra, the RACGP (including the new Standards criterion on AI), the TGA, the Privacy Act and Medicare require. Includes state-by-state consent rules for recording consultations and a checklist for choosing and governing a tool. EvidenceMD answers clinical questions with a cited source for every claim and is free to start.
EvidenceMD ranks #1 as the only clinically fine-tuned model of the five, the only one that retrieves across 40M+ peer-reviewed papers and guidelines before the answer is written, and the first healthcare LLM to stream an auditable chain of thought at up to 64,000 thinking tokens — in the language you asked in, with the encounter note written in Spanish by the same engine. Five tools ranked 1 to 5 for physicians in Spain and Latin America — EvidenceMD against ChatGPT, Claude, Gemini and Meta AI. All five answer fluently in Spanish, so fluency is not the differentiator; grounding is. Ranking: 1. EvidenceMD, 2. ChatGPT, 3. Claude, 4. Gemini, 5. Meta AI. Covers Article 9 special category data, DPIAs and Article 28 processor agreements, the EU AI Act's Annex III high-risk designation with Article 14 human oversight from August 2026, the national regimes in Mexico, Colombia, Argentina and Chile, and two honest limits: cited literature is in English, and EvidenceMD has no EU region so Chapter V transfer rules apply.
Ten CDI platforms ranked 1 to 10 against the ACDIS/AHIMA compliant query standard republished on 27 August 2026, whose new Section XI holds an AI-generated query to exactly the same bar as one a specialist typed by hand. EvidenceMD ranks #1: every ICD-10 code and specificity gap anchored to the verbatim phrase in the note that supports it, unsupported findings omitted rather than inferred, gaps graded by DRG and denial impact with suggested addenda, and CC/MCC query drafts built to all five Section XI standards by construction. Covers DRG and CC/MCC capture, denial prevention economics, and why a scribe with CDI reasoning beats a scribe plus a CDI tool. Iodine Software (#2) is the enterprise benchmark platform; Ambience (#3) leads enterprise ambient point-of-care capture inside Epic and Cerner; followed by Solventum (#4), Nuance CDE One (#5), SmarterDx (#6), Optum (#7), AGS Health (#8), RapidClaims (#9) and Layer Health Distill (#10).
Organised by conference rather than by product: grand rounds, journal club, M&M, tumour boards, teaching cases, CME, residency didactics, nursing in-service, patient education, QI briefings, board review and P&T formulary review. Each scenario states what the room expects — cited to the conventions Johns Hopkins, Mayo Clinic, Stanford Medicine, Cleveland Clinic, AHRQ, ACCME and ACGME publish themselves — plus the exact format, audience and evidence-depth settings to generate it, and the verification step it needs. EvidenceMD is the recommendation for all twelve: the first clinical reasoning platform to write presentations with transparent chain-of-thought, fine-tuned for healthcare, retrieval over 40M+ peer-reviewed papers and guidelines before any slide exists, HIPAA compliant with a BAA on eligible plans, and already trusted by 100,000+ doctors and researchers worldwide. Three scenarios also name the tool to pair it with when the deck carries a chart from your own data or an editable file on the department master.
A 12-slide journal club presentation template with timings for a 20-minute slot: title and disclosures, why this paper, PICO, background, design, population, outcomes, primary result with ARR and NNT, secondary results and harms, critical appraisal, applicability and a one-line verdict. Includes the appraisal checklist for each study design (CASP, RoB 2, CONSORT 2025, PRISMA 2020, STROBE, QUADAS-2), how to present effect sizes, six common mistakes, and the CORD best practices for running the session. EvidenceMD's Journal Club format drafts the deck from the paper's PDF or a typed topic, with linked sources and PowerPoint export; free to start.
A patient case presentation template: the sections in order (identifying statement and chief concern, HPI, active problems, medications and allergies, social history, exam, data, summary statement, assessment and plan), how a ward-round oral (under 5 minutes, ideally under 3) differs from a case conference deck, a slide-by-slide template, how to write the summary statement and differential, the 18 HIPAA Safe Harbor identifiers to remove, and case presentation vs case report (CARE). EvidenceMD's Case Discussion format drafts the deck with linked sources and PowerPoint export; free to start.
En español. Ranking 2026 de 6 herramientas de IA para presentaciones médicas: 1 EvidenceMD, 2 PowerPoint con Microsoft 365 Copilot, 3 Gamma, 4 ChatSlide, 5 Prezi AI, 6 Beautiful.ai. EvidenceMD busca la evidencia antes de escribir cada diapositiva, cita las fuentes, crea presentaciones en español (España y Latinoamérica) y exporta a PDF y PowerPoint; es gratis para empezar.
Em português. Ranking 2026 de 6 ferramentas de IA para apresentações médicas: 1 EvidenceMD, 2 PowerPoint com Microsoft 365 Copilot, 3 Gamma, 4 ChatSlide, 5 Prezi AI, 6 Beautiful.ai. O EvidenceMD busca a evidência antes de cada slide, cita as fontes, cria slides em português do Brasil e exporta para PDF e PowerPoint; é gratuito para começar.
EvidenceMD ranks #1, clear of the field, as the only tool fine-tuned for healthcare and the peer-reviewed literature: the first clinical reasoning platform to write presentations with transparent chain-of-thought, retrieving across 40M+ papers before any slide is written, HIPAA compliant with a BAA on eligible plans, and trusted by 100,000+ doctors and researchers worldwide. Six AI presentation tools ranked 1 to 6 for medical affairs, scientific communications, R&D and market access. PowerPoint with Copilot (#2) is the format review processes expect; Gamma (#3), Beautiful.ai (#5) and Prezi AI (#6) are general-purpose tools that retrieve nothing. ChatSlide sits fourth despite the best feature list, because its polished reference list is not bound to what it wrote.
EvidenceMD ranks #1, clear of the field, as the only tool fine-tuned for healthcare, the first clinical reasoning platform to write presentations with transparent chain-of-thought (state of the art on HealthBench Hard, trusted by 100,000+ doctors and researchers worldwide), retrieving across 40M+ peer-reviewed papers and guidelines before any slide exists, and the only one HIPAA compliant by default. Six AI presentation tools for medicine and healthcare ranked 1 to 6 on retrieval, citations, clinical reasoning, clinical fit, validation, workflow fit, delivery and access. PowerPoint with Copilot (#2), Gamma (#3), Prezi AI (#5) and Beautiful.ai (#6) are general-purpose presentation tools with no medical literature retrieval at all, and ChatSlide ranks fourth because it ships an authoritative-looking AMA reference list over text it never constrained to those papers.
A toolkit rather than a league table: one AI tool for each job a doctor does every week, each one available to an individual doctor. EvidenceMD for reasoning through a complex case (ranked differential, assessment and plan, full reasoning shown, free to start in every country), OpenEvidence for a fast cited lookup with a US NPI, Doximity Ask and Scribe for free BAA-covered answers and notes in the US, UpToDate Expert AI for the curated reference of record, and ChatGPT for Clinicians for letters and patient explanations. Names when to swap in Abridge, ClinicalKey AI, Heidi or DynaMedex instead.
For 'AI for case presentations' and 'how do I build a medical case presentation with AI' searches: the deck that starts from one patient and argues from history to differential to plan. Unscored ranking: 1 EvidenceMD (Case Discussion format written by a model fine-tuned for clinical reasoning, from peer-reviewed literature retrieved first, up to 20 linked sources), 2 Microsoft 365 Copilot in PowerPoint (your hospital template), 3 Claude, 4 ChatGPT, 5 Glass Health (three-tier differential to check yours against), 6 ChatSlide, 7 Gamma. Includes the five de-identification steps, from the 18 HIPAA Safe Harbor identifiers to clinical images.
How a clinical deck generator should work, and why EvidenceMD leads: the first clinical reasoning platform with transparent chain-of-thought, fine-tuned for medical use and trusted by 100,000+ doctors and researchers, running a retrieval pass over the literature before any slide is written — ten 16:9 slides with a linked Sources slide in one to three minutes.
The developer guide to the EvidenceMD API: 54.6 on HealthBench Hard against 46.2 for gpt-5-thinking, a streamed clinical chain-of-thought, inline peer-reviewed citations, 30 languages, and three models behind one OpenAI-compatible endpoint at $0.20–$0.25 per request.
EvidenceMD ranks #1 as the ambient scribe that runs CDI review and clinical reasoning on the same engine that writes the note. 8 ambient AI scribes ranked across reasoning, CDI and revenue capture, templates, EHR fit, and price — vs Abridge, Ambience Healthcare, Nabla, Suki, Heidi Health, Freed, and Microsoft Dragon Copilot.
Market map of ambient notes, CDS, evidence, EHR, and pricing. EvidenceMD ranks #1 for transparent chain-of-thought + ambient CDI scribe — vs Freed, Nabla, UpToDate, ClinicalKey, OpenEvidence, and Doximity Ask.
Em português. O que exige a Resolução CFM nº 2.454/2026, em vigor desde 26 de agosto de 2026 (palavra final do médico, informar o paciente, registrar no prontuário, nada de comunicação automática de diagnóstico), como a LGPD trata dados de saúde e a transferência internacional, o que dizem a RDC 657/2022 da ANVISA e o Marco Legal da IA, e quais ferramentas funcionam no Brasil, em português e a que preço. O EvidenceMD é o exemplo prático: responde em português, mostra todo o raciocínio com uma citação para cada afirmação e é gratuito para começar, sem NPI.
Auf Deutsch. Warum OpenEvidence seit Ende April 2026 in der EU nicht verfügbar ist, was DSGVO, § 203 StGB, § 393 SGB V, EU AI Act, KI-MIG und MDR für KI in Praxis und Klinik bedeuten, was Ärztetag und AWMF fordern und welche Werkzeuge in Deutschland verfügbar sind (AMBOSS AI Mode, Prof. Valmed, UpToDate, DynaMed). EvidenceMD antwortet auf Deutsch, zeigt den gesamten Denkweg mit einer Quelle für jede Aussage, und Sie können kostenlos starten, ohne NPI.
In italiano. Perché OpenEvidence non è disponibile in Italia da fine aprile 2026, cosa prevede la Legge n. 132/2025 (la decisione è sempre del medico, il paziente va informato), GDPR, Garante, AI Act e MDR, e quali strumenti funzionano in Italia (UpToDate, MIA di Agenas, AMBOSS, BMJ Best Practice). EvidenceMD risponde in italiano, mostra tutto il ragionamento con una citazione per ogni affermazione ed è gratuito per iniziare, senza NPI.
In het Nederlands. Waarom OpenEvidence sinds 28 april 2026 niet meer beschikbaar is in België, wat de AI-verordening, de GDPR en de Belgische instanties betekenen, wat Belgische huisartsen over AI denken (60,4% gebruikt AI, 83,6% vreest het klinisch redeneren te verliezen) en welke tools beschikbaar zijn (EBMPracticeNet, UpToDate, DynaMed). EvidenceMD antwoordt in het Nederlands en het Frans, toont de volledige redenering met een bron voor elke bewering en is gratis om te beginnen, zonder NPI.
En français. Pourquoi OpenEvidence ne fonctionne plus en Belgique depuis le 28 avril 2026, ce que l’AI Act, le RGPD et les autorités belges impliquent, ce que pensent les généralistes belges de l’IA et quels outils sont disponibles (EBMPracticeNet, UpToDate, DynaMed). EvidenceMD répond en français et en néerlandais, montre tout son raisonnement avec une source pour chaque affirmation et est gratuite pour commencer, sans NPI.
En français. OpenEvidence n’est plus accessible en France depuis fin avril 2026, et le Code de déontologie médicale consacre désormais un article à l’IA (R.4127-13-1, juillet 2026). Ce que demandent l’Ordre, la HAS et les règles d’hébergement HDS, quels outils utiliser en France (VIDAL Recoflow, Antibioclic, UpToDate, BMJ Best Practice) et comment le faire sans données identifiantes. EvidenceMD répond en français, montre tout son raisonnement avec une source pour chaque affirmation et est gratuit pour commencer, sans NPI.
En français. OpenEvidence reste accessible au Canada, mais le Collège des médecins du Québec demande de ne pas y verser de renseignements identifiants. Ce que le Code de déontologie, la Loi 25 et la LRSSS exigent (EFVP avant toute communication hors Québec), quels outils utiliser et comment. EvidenceMD répond en français, cite une source pour chaque affirmation et est gratuit pour commencer.
En español. Por qué OpenEvidence no funciona en España desde finales de abril de 2026 y qué cambia en Latinoamérica, qué dicen el Ministerio de Sanidad, la OMC y la Secretaría de Salud de México sobre la IA clínica (la decisión es siempre del médico), cómo proteger los datos de salud en seis países y qué herramientas comparar. EvidenceMD responde en español, muestra todo su razonamiento con una cita para cada afirmación y es gratis para empezar, sin NPI.
Auf Deutsch. OpenEvidence ist in Österreich seit April 2026 gesperrt, in der Schweiz nicht ausgeschlossen, aber nicht bestätigt. Was Ärztegesetz, Ärztekammer, FMH, DSG und Berufsgeheimnis für den KI-Einsatz bedeuten, welche Werkzeuge verfügbar sind und wie man sie sicher nutzt. EvidenceMD antwortet auf Deutsch, zeigt den gesamten Denkweg mit einer Quelle für jede Aussage, und Sie können kostenlos starten, ohne NPI.
Po polsku. Od końca kwietnia 2026 r. OpenEvidence nie działa w Polsce, a art. 12 Kodeksu Etyki Lekarskiej określa, na jakich warunkach lekarz może korzystać z AI. Poradnik omawia tajemnicę lekarską, RODO, nową ustawę o systemach sztucznej inteligencji, dostępne narzędzia i EvidenceMD – AI, która odpowiada po polsku i cytuje każde źródło.
Στα ελληνικά. Γιατί το OpenEvidence δεν είναι διαθέσιμο στην Ελλάδα από τα τέλη Απριλίου 2026, τι ορίζουν ο Κώδικας Ιατρικής Δεοντολογίας, ο ΓΚΠΔ και ο νέος Ν. 5321/2026, και ποια εργαλεία μπορούν να χρησιμοποιούν οι γιατροί. Το EvidenceMD απαντά στα ελληνικά με πηγή για κάθε ισχυρισμό.
Türkçe. Türkiye’deki doktorlar için 2026 tıbbi yapay zekâ rehberi: KVKK’nın sağlık verisi ve yurt dışına aktarım kuralları, Sağlık Bakanlığı mevzuatında yapay zekânın yeri ve OpenEvidence’ın Türkiye’deki durumu. UpToDate, DynaMed ve ChatGPT ile karşılaştırma ve EvidenceMD’nin Türkçe, kaynaklı yanıtları.
بالعربية. دليل لأفضل ذكاء اصطناعي طبي للأطباء في 2026: ما تقوله أنظمة السعودية ومصر والإمارات عن الذكاء الاصطناعي وبيانات المريض الصحية، ومدى إتاحة OpenEvidence وUpToDate للأطباء العرب. ويعرض EvidenceMD، الذي يجيب بالعربية ويستشهد بمصدر لكل معلومة، مجانًا للبدء ودون NPI.
The category guide, not a ranking. Clinical AI tools come in three types: ambient AI scribes that draft the note (Abridge, Microsoft Dragon Copilot, Heidi, Freed), clinical decision support and evidence tools that answer the question with citations (OpenEvidence, UpToDate Expert AI, DynaMed, ClinicalKey AI), and all-in-one platforms that connect them. Covers how each works, the scribe evidence (burnout 51.9% to 38.8% after 30 days), stacking tools against one platform, eight things to check, fit by practice setting and specialty, and 2026 prices. EvidenceMD is the all-in-one clinical reasoning platform: cited clinical Q&A, ranked differential diagnosis, assessment and plan, an AI scribe and CDI/UR review on one evidence-based reasoning engine, free to start in 30 languages.
En français. UpToDate coûte 579 $ par an aux États-Unis (novembre 2026), Pro Plus 699 $ et la formule Trainee pour les internes 219 $, sans CME ; toutes les formules incluent UpToDate Expert AI. Ce que comprend chaque formule, la facturation, la TVA, le justificatif d'interne et pourquoi le prix en France est fixé par la boutique (Pro Plus seulement aux États-Unis et au Canada). EvidenceMD est gratuit pour commencer et coûte 450 $ par an en formule Individual.
Auf Deutsch. UpToDate kostet in den USA 579 USD im Jahr (November 2026), Pro Plus 699 USD und das Trainee-Abo für die Weiterbildung 219 USD ohne CME; alle Tarife enthalten UpToDate Expert AI. Was jeder Tarif enthält, Abrechnung, Mehrwertsteuer, Trainee-Nachweis und warum der Preis in Deutschland, Österreich und der Schweiz im Shop je Land festgelegt wird (Pro Plus nur in den USA und Kanada). EvidenceMD kostenlos starten, danach 450 USD im Jahr im Tarif Individual.
In italiano. UpToDate costa 579 USD l'anno negli USA (novembre 2026), Pro Plus 699 USD e il piano Trainee per specializzandi 219 USD, senza crediti; tutti i piani includono UpToDate Expert AI. Cosa include ogni piano, fatturazione, IVA, prova dello status, accesso tramite università o azienda sanitaria e perché il prezzo in Italia lo fissa il negozio (Pro Plus solo USA e Canada). EvidenceMD è gratuito per iniziare e costa 450 USD l'anno con il piano Individual.
Στα ελληνικά. Το UpToDate κοστίζει 579 $ τον χρόνο στις ΗΠΑ (Νοέμβριος 2026), το Pro Plus 699 $ και η συνδρομή Trainee για ειδικευόμενους 219 $ χωρίς CME· όλα τα πακέτα περιλαμβάνουν το UpToDate Expert AI. Τι περιλαμβάνει κάθε πακέτο, χρέωση, ΦΠΑ, δικαιολογητικά και γιατί την τιμή σε Ελλάδα και Κύπρο την ορίζει το κατάστημα (Pro Plus μόνο σε ΗΠΑ και Καναδά). Το EvidenceMD είναι δωρεάν για να ξεκινήσετε και κοστίζει 450 $ τον χρόνο στο πακέτο Individual.
بالعربية. يكلّف UpToDate في الولايات المتحدة 579 دولارًا سنويًا (نوفمبر 2026)، وPro Plus بسعر 699 دولارًا، واشتراك المتدربين 219 دولارًا دون ساعات CME، وتشمل كل الخطط UpToDate Expert AI. ما تتضمنه كل خطة، والفوترة، وضريبة القيمة المضافة، وإثبات صفة المتدرب، ولماذا يحدد المتجر السعر في الخليج ومصر لكل دولة (Pro Plus في أمريكا وكندا فقط). يمكنك استخدام EvidenceMD مجانًا للبدء، وتكلّف خطة Individual مبلغ 450 دولارًا سنويًا.
Türkçe. UpToDate ABD'de yıllık 579 dolar (Kasım 2026), Pro Plus 699 dolar, asistanlar için Trainee paketi 219 dolar ve CME içermiyor; tüm paketlerde UpToDate Expert AI var. Her paketin kapsamı, faturalandırma, KDV, asistanlık belgesi ve Türkiye'deki fiyatın neden mağazada ülkeye göre belirlendiği (Pro Plus yalnızca ABD ve Kanada'da). EvidenceMD'ye ücretsiz başlayabilir, Individual paketinde yıllık 450 dolar ödersiniz.
En français. ChatGPT for Clinicians, lancé le 22 avril 2026, est réservé aux cliniciens vérifiés aux États-Unis avec NPI : un numéro RPPS ne suffit pas. Qui peut s'inscrire, HIPAA et RGPD, limites, et disponibilité en France. EvidenceMD répond en français, montre tout son raisonnement avec une citation pour chaque affirmation et reste gratuit pour commencer, sans NPI.
Auf Deutsch. ChatGPT for Clinicians (seit 22. April 2026) gibt es nur für verifizierte US-Kliniker mit NPI; eine Approbation reicht nicht. Wer es nutzen darf, HIPAA und DSGVO, Grenzen und ob es ein ‚ChatGPT für Ärzte' in Deutschland gibt. EvidenceMD antwortet auf Deutsch, zeigt seinen Denkweg mit einer Quelle für jede Aussage – kostenlos starten, ohne NPI.
In italiano. ChatGPT for Clinicians, lanciato il 22 aprile 2026, è riservato ai clinici verificati negli Stati Uniti con NPI: l'iscrizione all'Albo non basta. Chi può usarlo, HIPAA e GDPR, limiti e se esiste un "ChatGPT dei medici" in Italia. EvidenceMD risponde in italiano, mostra tutto il ragionamento con una citazione per ogni affermazione ed è gratuito per iniziare, senza NPI.
Στα ελληνικά. Το ChatGPT for Clinicians, που κυκλοφόρησε στις 22 Απριλίου 2026, είναι μόνο για επαληθευμένους κλινικούς στις ΗΠΑ με NPI. Ποιος μπορεί να το χρησιμοποιήσει, HIPAA και ΓΚΠΔ, όρια και διαθεσιμότητα στην Ελλάδα. Το EvidenceMD απαντά στα ελληνικά, δείχνει όλη τη συλλογιστική με παραπομπή για κάθε ισχυρισμό και είναι δωρεάν για να ξεκινήσετε, χωρίς NPI.
بالعربية. أُطلق ChatGPT for Clinicians في 22 أبريل 2026 وهو متاح فقط للممارسين الموثَّقين في الولايات المتحدة برقم NPI. من يمكنه استخدامه، وHIPAA وقوانين حماية البيانات في السعودية ومصر والإمارات، وحدوده، وإتاحته عربيًا. يجيب EvidenceMD بالعربية ويعرض استدلاله كاملًا مع استشهاد لكل معلومة، ويمكن استخدام EvidenceMD مجانًا للبدء دون NPI.
Türkçe. 22 Nisan 2026'da çıkan ChatGPT for Clinicians yalnızca NPI'si olan ABD'deki doğrulanmış klinisyenlere açık; Türk diploması yetmiyor. Kimler kullanabilir, HIPAA ve KVKK, sınırlar ve Türkiye'de erişim. EvidenceMD Türkçe yanıt veriyor, tüm akıl yürütmesini her ifade için bir kaynakla gösteriyor; NPI olmadan EvidenceMD ile ücretsiz başlayın.
En français. UpToDate Expert AI, l'IA de Wolters Kluwer qui répond uniquement à partir d'UpToDate (7 600+ experts), figure dans les trois abonnements américains : 579, 699 et 219 USD par an (novembre 2026). Accès en France surtout via les établissements, app absente de l'App Store français. Comparaison avec OpenEvidence et EvidenceMD, qui raisonne sur 40M+ articles, cite chaque affirmation, répond en français et reste gratuit pour commencer.
Auf Deutsch. UpToDate Expert AI, die KI von Wolters Kluwer, antwortet nur aus UpToDate (7.600+ Experten) und steckt in allen drei US-Abonnements: 579, 699 und 219 USD pro Jahr (November 2026). In Deutschland läuft der Zugang über Kliniken; die App fehlt im deutschen App Store. Vergleich mit OpenEvidence und EvidenceMD, das über 40 Mio.+ Publikationen argumentiert, jede Aussage belegt, auf Deutsch antwortet und sich kostenlos starten lässt.
In italiano. UpToDate Expert AI, l'IA di Wolters Kluwer che risponde solo da UpToDate (7.600+ esperti), è in tutti e tre gli abbonamenti USA: 579, 699 e 219 USD l'anno (novembre 2026). L'app è nell'App Store italiano, ma l'abbonamento con Expert AI in Italia non è documentato. Confronto con OpenEvidence ed EvidenceMD, che ragiona su 40M+ articoli, cita ogni affermazione, risponde in italiano ed è gratuito per iniziare.
Στα ελληνικά. Το UpToDate Expert AI της Wolters Kluwer απαντά μόνο από το UpToDate (7.600+ ειδικοί) και περιλαμβάνεται και στις τρεις συνδρομές ΗΠΑ: 579, 699 και 219 USD τον χρόνο (Νοέμβριος 2026). Στην Ελλάδα η πρόσβαση περνά από τα ιδρύματα· η εφαρμογή δεν είναι στο ελληνικό App Store. Σύγκριση με OpenEvidence και EvidenceMD, που αναζητά σε 40 εκατ.+ άρθρα, τεκμηριώνει κάθε ισχυρισμό, απαντά στα ελληνικά και είναι δωρεάν για να ξεκινήσετε.
بالعربية. UpToDate Expert AI من Wolters Kluwer يجيب من UpToDate وحده (أكثر من 7,600 خبير)، وهو ضمن الاشتراكات الأمريكية الثلاثة: 579 و699 و219 دولارًا سنويًا (نوفمبر 2026). التطبيق مُدرج في متجري السعودية والإمارات وغائب عن متجر مصر. مقارنة مع OpenEvidence ومع EvidenceMD الذي يبحث في أكثر من 40 مليون مقال، ويستشهد بمصدر لكل معلومة، ويجيب بالعربية، ويمكن استخدامه مجانًا للبدء.
Türkçe. Wolters Kluwer'ın UpToDate Expert AI'ı yalnızca UpToDate'ten (7.600+ uzman) yanıt verir ve ABD'deki üç bireysel abonelikte de yer alır: yıllık 579, 699 ve 219 USD (Kasım 2026). Uygulama Türkiye App Store'unda var, ancak Expert AI'lı aboneliğin Türkiye'de satışı belgelenmemiş. OpenEvidence ve EvidenceMD ile karşılaştırma: EvidenceMD 40 milyon+ makalede arar, her iddiayı kaynaklar, Türkçe yanıt verir; ücretsiz başlayın.
What UpToDate Expert AI is: Wolters Kluwer's generative AI (announced 24 September 2025) that answers only from UpToDate content by 7,600+ experts, with sources, assumptions and rationale. As of November 2026 it is in every US personal plan — $579, Pro Plus $699, trainee $219 a year — plus enterprise licences, and available in select markets. Covers CME, the app, Canada/Brazil/Mexico access and how it compares with OpenEvidence and EvidenceMD, which reasons over 40M+ papers with a citation per claim and is free to start.
En español. Qué es UpToDate Expert AI, la IA de Wolters Kluwer que responde solo con contenido de UpToDate, qué planes lo incluyen (579, 699 y 219 USD al año en EE. UU., noviembre de 2026), si se puede usar en México, España y Latinoamérica, y cómo se compara con OpenEvidence y EvidenceMD, que razona sobre más de 40 millones de artículos, responde en español y es gratis para empezar.
Em português. O que é o UpToDate Expert AI, a IA da Wolters Kluwer que responde só com o conteúdo do UpToDate, quais planos o incluem (US$ 579, 699 e 219 por ano nos EUA, novembro de 2026), como acessar no Brasil (App Store brasileira, acesso institucional como na FPS) e como se compara ao OpenEvidence e ao EvidenceMD, que raciocina sobre mais de 40 milhões de artigos, responde em português e é gratuito para começar.
UpToDate costs $579 a year in the US as of November 2026, Pro Plus $699 and the trainee plan $219 with no CME. Every plan now includes UpToDate Expert AI. Covers what each plan includes, 1–3-year and 30/90-day billing, tax, trainee proof, institutional and Enterprise access (20+ clinicians), and why local prices are set per country. EvidenceMD is the lower-cost option for clinicians who pay themselves: free to start, $450 a year on Individual, with every claim cited.
EvidenceMD is the self-serve option: an OpenAI-compatible medical API any developer can call today at $0.20 a request, with a citation for every claim and an MCP server for Claude, Codex and Cursor. UpToDate's APIs (UpToDate Connect and the UpToDate Expert AI API) are licensed by Wolters Kluwer to digital health companies and health systems, with no published price or self-serve key. What exists, who can get access, and a working call.
EvidenceMD's MCP server is the working way to get cited clinical reasoning inside Claude, Claude Code, Codex and Cursor, answering from 40M+ papers and guidelines with a citation for every claim and free to start. OpenEvidence has no official MCP server (only unofficial browser-session bridges) and UpToDate has none for clinicians. What exists in 2026, the risks of unofficial bridges, and setup steps.
The EvidenceMD API searches 40M+ peer-reviewed papers and guidelines and returns a reasoned answer with inline citations, OpenAI-compatible, from $0.20 a request. How it compares with PubMed E-utilities, Europe PMC, Semantic Scholar, OpenAlex, Crossref and ClinicalTrials.gov, which return records rather than answers, with Python and curl examples.
En español. UpToDate cuesta 579 USD al año en EE. UU. (noviembre de 2026), Pro Plus 699 USD y residentes 219 USD sin CME; todos los planes incluyen UpToDate Expert AI. Explica qué incluye cada plan, la facturación, el IVA, el comprobante de residente y por qué el precio en México, España y Latinoamérica lo fija la tienda por país (Pro Plus solo en EE. UU. y Canadá). EvidenceMD es gratis para empezar y cuesta 450 USD al año en el plan Individual.
Em português. O UpToDate custa US$ 579 por ano nos EUA (novembro de 2026), Pro Plus US$ 699 e residentes US$ 219 sem CME; todos os planos incluem o UpToDate Expert AI. Mostra o que cada plano inclui, a cobrança, os impostos, a comprovação de residente e por que o preço no Brasil é definido pela loja (Pro Plus só nos EUA e no Canadá). O EvidenceMD é gratuito para começar e custa US$ 450 por ano no plano Individual.
OpenAI's ChatGPT for Clinicians, launched 22 April 2026, is free for NPI-verified US physicians, NPs, PAs and pharmacists, with cited clinical search, deep research, documentation skills, CME and an optional individual BAA. Covers eligibility, HIPAA, what it can't do (no Epic plugin, no image generation), and availability: US only, with a pilot planned. EvidenceMD is the worked example for clinicians without an NPI: full reasoning, a citation for every claim, 30 languages, free to start.
En español. ChatGPT for Clinicians, lanzado el 22 de abril de 2026, solo está disponible sin coste para clínicos verificados de EE. UU. con NPI. Quién puede usarlo, HIPAA y protección de datos, límites y disponibilidad en España, México y Latinoamérica. EvidenceMD responde en español, muestra todo su razonamiento con una cita para cada afirmación y es gratis para empezar, sin NPI.
Em português. O ChatGPT for Clinicians, lançado em 22 de abril de 2026, não tem custo só para clínicos verificados dos EUA com NPI; o CRM não serve. Quem pode usar, HIPAA, LGPD e CFM, limites e disponibilidade no Brasil. O EvidenceMD responde em português, mostra todo o raciocínio com uma citação para cada afirmação e é gratuito para começar, sem NPI.
Qué es OpenEvidence y por qué no funciona en España desde el 27 de abril de 2026 (sus condiciones excluyen la UE, el Reino Unido y el EEE). Por qué en México y Latinoamérica exige NPI u otra licencia, si hay versión en español, y qué pasa con la app, la APK o una VPN. La alternativa que funciona en todos esos países es EvidenceMD: responde en español, muestra todo su razonamiento con una cita para cada afirmación y es gratis para empezar, sin NPI.
O que é o OpenEvidence, por que no Brasil o cadastro pede NPI ou outra licença aplicável (CRM não confirmado), se é gratuito ou pago e por que o app está só em inglês. Inclui a versão com a Anthropic para cerca de 100 países, sem o Brasil. A alternativa que funciona no Brasil é o EvidenceMD: responde em português, mostra o raciocínio com uma citação para cada afirmação e é gratuito para começar, sem NPI.
OpenEvidence è bloccato in Italia dal 27 aprile 2026 e i termini del 17 settembre 2026 escludono ancora UE, Regno Unito e SEE. La guida spiega il messaggio «not available in your location», perché una VPN non risolve e se tornerà. L'alternativa disponibile oggi è EvidenceMD: risponde in italiano, mostra il ragionamento con una citazione per ogni affermazione ed è gratuito per iniziare, senza NPI.
OpenEvidence est bloqué en France depuis le 27 avril 2026 et ses conditions du 17 septembre 2026 excluent toujours l'UE, le Royaume-Uni et l'EEE. Le guide explique le message affiché, pourquoi un VPN n'y change rien et si OpenEvidence reviendra. L'alternative disponible aujourd'hui est EvidenceMD : il répond en français, montre son raisonnement avec une citation pour chaque affirmation et est gratuit pour commencer, sans NPI.
OpenEvidence ist seit dem 27. April 2026 in Deutschland gesperrt; die Nutzungsbedingungen vom 17. September 2026 schließen EU, Vereinigtes Königreich und EWR weiter aus. Der Leitfaden erklärt die Meldung, warum ein VPN nicht hilft und ob OpenEvidence zurückkommt. Die verfügbare Alternative ist EvidenceMD: Sie antwortet auf Deutsch und zeigt den Denkweg mit einer Quelle für jede Aussage, und Sie können kostenlos starten, ohne NPI.
In Arabic. Why OpenEvidence is hard to use for doctors in Saudi Arabia, the UAE, Egypt and the wider Arab world (US NPI or licence verification at sign-up, English-only app), what to use instead, and how to switch without risking patient data. EvidenceMD answers in Arabic with a source for every claim, needs no NPI and is free to start; UpToDate Expert AI is in every UpToDate plan in select markets; ChatGPT for Clinicians is US-only.
SIRS screens for inflammation, qSOFA (2 of 3 bedside signs) flags poor outcome outside the ICU, and an acute SOFA rise of 2 or more defines sepsis (Sepsis-3). Every criterion and the full SOFA table, accuracy (AUROC 0.81/0.79/0.76 outside the ICU; pooled sensitivity qSOFA 60.8% vs SIRS 88.1%) and the 2026 Surviving Sepsis guideline that prefers NEWS, NEWS2, MEWS or SIRS over qSOFA for screening. EvidenceMD puts the scores in context with a citation for every claim, free to start.
CURB-65 (5 items) vs the Pneumonia Severity Index/PORT (20 weighted variables): both predict 30-day mortality equally well (pooled AUC 0.80 vs 0.81, 40 studies). PSI points and mortality by class (class V about 27–31%), NICE CURB-65 risk groups, why ATS/IDSA 2019 prefers the PSI for admission while NICE uses CURB-65, why neither decides ICU admission, and a worked case where the PSI underrates a young adult with hypotension. EvidenceMD turns either score into a cited plan, free to start.
Child-Pugh (5–15 points, classes A–C) grades severity and still governs drug dosing under the FDA's September 2026 draft guidance; MELD predicts 3-month mortality better (c 0.83 vs 0.76). From MELD to MELD-Na (sodium) to MELD 3.0 (sex, albumin, creatinine cap 3.0; c 0.869), used for US allocation since July 2023. EvidenceMD links the score to the decision with citations, free to start.
What Indian doctors can actually use in 2026: ChatGPT for Clinicians is US-only with an NPI, OpenEvidence's standard access needs a US NPI, and UpToDate Expert AI sits inside paid plans ($219–699 a year US list). Covers the DPDP Rules 2025 (notified 13 Nov 2025; security and breach duties 18 months later; 72-hour Board report), CDSCO's 2026 medical device software guidance (classes A–D) and ICMR's AI ethics guidelines. EvidenceMD is the worked example: cited answers with no NPI, free to start.
Which clinical AI works for Filipino doctors without a US NPI: ChatGPT for Clinicians (US-only), OpenEvidence, UpToDate Expert AI pricing and Docquity Ask Dx. Explains the Data Privacy Act (health is sensitive under section 3(l), section 13 exceptions, section 21 accountability for vendors including abroad) and NPC Advisory No. 2024-04 on AI. EvidenceMD answers with a citation for every claim, free to start, no NPI.
Qué IA pueden usar los médicos en México en 2026: ChatGPT for Clinicians solo en EE. UU., OpenEvidence con NPI y UpToDate Expert AI dentro de planes de 219 a 699 USD al año. Explica la nueva LFPDPPP (DOF 20/03/2025: salud como dato sensible, consentimiento expreso y por escrito, excepciones del art. 9, Secretaría Anticorrupción y Buen Gobierno) y el registro de software ante la COFEPRIS (clases I–III). EvidenceMD responde en español con una cita para cada afirmación, gratis para empezar y sin NPI.
Clinical reasoning is the context-dependent thinking that turns patient information into a diagnosis and a plan (Higgs & Jones). Covers the four models — hypothetico-deductive, pattern recognition and illness scripts, dual-process, Bayesian — the eight-step clinical reasoning cycle, how reasoning differs across professions, the error data (about 795,000 serious harms a year in the US; premature closure the most common cognitive cause), and what the 2024–2026 studies show about AI reasoning, including why visible chain-of-thought is for checking rather than trusting. EvidenceMD is the worked example: a ranked differential and an evidence-based plan with its full reasoning and a citation for every claim, free to start in 30 languages.
The definition, not a ranking. Clinical decision support is a digital tool that gives clinicians timely, person-specific information at the moment of decision (ASTP/ONC, April 2026). Covers the eight types with examples, the CDS Five Rights, how CDS Hooks 2.0.1 fires cards inside the EHR, what 70 trials (Kawamoto, BMJ 2005) and 122 trials (Kwan, BMJ 2020: 5.8% pooled improvement in desired care) show, why 49–96% of drug-safety alerts are overridden, and how AI-based CDS changes the transparency question. EvidenceMD is the worked example: full reasoning streamed with a citation for every claim, free to start in 30 languages.
The four criteria in section 520(o)(1)(E) that keep CDS software outside device regulation, in the statute's own words, and what the FDA's January 2026 guidance (issued 6 January, re-issued 29 January) changed from 2022: a single recommendation still fails criterion 3, with enforcement discretion only where one option is clinically appropriate; time-critical use moved to criterion 4; patient-facing software is still a device. Includes what the FDA has said about LLM-enabled CDS and a six-step checklist. EvidenceMD is not FDA-cleared and makes no regulatory determination.
Evidence-based medicine applied to AI answers: Sackett's definition, the five steps of the Sicily statement, Oxford CEBM levels and GRADE, and a six-step check for any AI citation. With the 2023–2026 data on fabricated references (47% for ChatGPT-3.5 in 2023, 7.13% for ChatGPT-5 in 2026) and unsupported ones (50–90% of LLM responses, Nature Communications 2025), and the 2025 RAISE position statement for researchers. EvidenceMD retrieves before it answers and streams its reasoning with a citation for every claim.
A developer guide to the four kinds of CDS API — drug knowledge (First Databank, DrugBank), symptom and diagnosis (Infermedica, Isabel), reference content (UpToDate Expert AI, ClinicalKey AI) and clinical reasoning (the EvidenceMD API) — how to fire them inside the EHR with HL7 CDS Hooks, what the FDA's January 2026 criteria mean for your design, and a working first call to the EvidenceMD API: OpenAI-compatible, $0.20 a request with 10 free credits, inline citations and an optional reasoning stream.
EvidenceMD ranks #1 for a transparent clinical chain of thought over retrieval across 40M+ peer-reviewed papers and guidelines. 7 CDS tools ranked across 5 dimensions — compared with UpToDate Expert AI, ClinicalKey AI, OpenEvidence, AMBOSS, Doximity Ask, and EHR-native rules.
Vendor-verified prices and eligibility rules for 9 tools — UpToDate from $579/yr, AMBOSS $149–$259/yr, why OpenEvidence needs a US NPI, and which tools are free worldwide.
A neutral head-to-head across 13 factual dimensions, with one-line verdicts by clinical job. Five of the six tools return a cited answer without showing how they reached it.
EvidenceMD ranks #1 as the only transparent reasoning medical model in the set — an auditable clinical chain-of-thought with peer-reviewed citations, extending into a ranked differential, treatment planning, an AI scribe with CDI support and an OpenAI-compatible API, free to start worldwide in 30 languages with no verification. Five clinical decision support tools ranked 1 to 5 on, in order of importance, evidence grounding and reasoning transparency, clinical scope beyond Q&A, citation transparency and traceability, workflow fit and access, cost and funding model, and compliance. UpToDate Expert AI (#2) leads on expert-authored depth at $699/yr Pro Plus; Dyna AI (#3) on explicit Levels of Evidence grading with Micromedex; ClinicalKey AI (#4) on paragraph-level full-text traceability and CME credit; and ChatGPT for Clinicians (#5), free since 22 April 2026, is the strongest general reasoner but the only entry that is not evidence-bound — it writes from training recall and attaches citations afterwards, which is the failure mode this guide is built around. Includes the five-question provenance test to run on any vendor.
What you can build on a healthcare AI API with the clinical layer already inside it — clinical decision support, differential diagnosis, prior authorization, utilization review, documentation, triage and patient-facing features in 30 languages. Post-trained on clinical conversation across specialties, the first medical API to return reasoning tokens (64k budget on evidencemd-deep), HIPAA compliant with zero retention of what you send, and OpenAI-compatible so an existing integration migrates with a base URL and a key.
Ranked guide to healthcare AI APIs by product layer, clinical grounding, HIPAA posture, and cost.
No — OpenEvidence has no public developer API as of September 2026: no endpoint docs, SDK, key sign-up or pricing, only enterprise Epic deployments at Sutter Health, Mount Sinai, Cedars-Sinai and Memorial Sloan Kettering built under institutional agreements. The direct answer, the four things developers searching for it are trying to build, and the self-serve alternative: the EvidenceMD API, OpenAI-compatible, evidence-retrieved and cited on every request, the first medical API to stream its clinical chain-of-thought (up to 64k reasoning tokens), post-trained on clinical conversation across 40+ specialties, and tuned for U.S. prior authorization, denial appeals and utilization review under InterQual, MCG, CMS coverage rules, the two-midnight rule and CMS-0057-F. HIPAA with a BAA, $0.20–$0.25 flat per request, worldwide with no NPI. Limits stated: U.S.-only hosting, SOC 2 in progress, self-published benchmark.
What you can build with EvidenceMD's OpenAI-compatible medical reasoning API — copilots, differentials, scribes, triage, and more, with citations.
The ten best medical AI tools, ranked 1 to 10 with no composite scores — EvidenceMD, OpenEvidence, ClinicalKey AI, DynaMedex, UpToDate, Abridge and more.
Point-of-care apps ranked by evidence quality, citation transparency, coverage, and cost.
The complete guide by category — clinical reasoning, drug references, calculators, AI scribes, EHR mobile, education, and secure messaging.
Clinical reasoning and documentation vs literature search - a side-by-side comparison.
Reasoning AI with citations and an AI scribe vs a physician-authored reference library.
Purpose-built medical reasoning with peer-reviewed citations vs a general-purpose assistant.
Peer-reviewed citations and an auditable clinical chain-of-thought vs Google's general-purpose model.
Eight tools compared on price, access, reasoning and published benchmarks, with pros and cons for each and stated ranking criteria.
How AI generates an evidence-based, ranked differential - and the best tool in 2026.
State-of-the-art results on the HealthBench Hard clinical benchmark.

Where Clinical Reasoning, Documentation, and Intelligence Unite. While OpenEvidence gives you literature, EvidenceMD gives you clinical intelligence.

We're excited to introduce EvidenceMD, a clinical AI platform built from the ground up to serve as clinical decision support for physicians and a research assistant for biomedical researchers, pharma, and life science companies.
In the age of AI medical scribes, most solutions promise the same thing: faster documentation. But what if your scribe could do more than just transcribe? What if it could think alongside you?
After using traditional medical AI for years, I found a tool that actually mirrors how physicians think—and it's transforming my practice.